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Summary
Background—Remarkable financial and political efforts have been focused on the reduction of
child mortality during the past few decades. Timely measurements of levels and trends in under-5
mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4)
target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of
success.
Methods—We generated updated estimates of child mortality in early neonatal (age 0–6 days),
late neonatal (7–28 days), postneonatal (29–364 days), childhood (1–4 years), and under-5 (0–4
years) age groups for 188 countries from 1970 to 2013, with more than 29 000 survey, census,
vital registration, and sample registration datapoints. We used Gaussian process regression with
adjustments for bias and non-sampling error to synthesise the data for under-5 mortality for each
country, and a separate model to estimate mortality for more detailed age groups. We used
explanatory mixed effects regression models to assess the association between under-5 mortality
and income per person, maternal education, HIV child death rates, secular shifts, and other factors.
To quantify the contribution of these different factors and birth numbers to the change in numbers
of deaths in under-5 age groups from 1990 to 2013, we used Shapley decomposition. We used
estimated rates of change between 2000 and 2013 to construct under-5 mortality rate scenarios out
to 2030.
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Findings—We estimated that 6·3 million (95% UI 6·0–6·6) children under-5 died in 2013, a 64%
reduction from 17·6 million (17·1–18·1) in 1970. In 2013, child mortality rates ranged from 152·5
per 1000 livebirths (130·6–177·4) in Guinea-Bissau to 2·3 (1·8–2·9) per 1000 in Singapore. The
annualised rates of change from 1990 to 2013 ranged from −6·8% to 0·1%. 99 of 188 countries,
including 43 of 48 countries in sub-Saharan Africa, had faster decreases in child mortality during
2000–13 than during 1990–2000. In 2013, neonatal deaths accounted for 41·6% of under-5 deaths
compared with 37·4% in 1990. Compared with 1990, in 2013, rising numbers of births, especially
in sub-Saharan Africa, led to 1·4 million more child deaths, and rising income per person and
maternal education led to 0·9 million and 2·2 million fewer deaths, respectively. Changes in
secular trends led to 4·2 million fewer deaths. Unexplained factors accounted for only −1% of the
change in child deaths. In 30 developing countries, decreases since 2000 have been faster than
predicted attributable to income, education, and secular shift alone.
Interpretation—Only 27 developing countries are expected to achieve MDG 4. Decreases since
2000 in under-5 mortality rates are accelerating in many developing countries, especially in sub-
Saharan Africa. The Millennium Declaration and increased development assistance for health
might have been a factor in faster decreases in some developing countries. Without further
accelerated progress, many countries in west and central Africa will still have high levels of
under-5 mortality in 2030.
Funding—Bill & Melinda Gates Foundation, US Agency for International Development.
Introduction
During the past few decades, substantial political, donor, and country focus has been placed
on the reduction of child mortality. The Millennium Development Goal 4 (MDG 4) target of
reduction of child mortality by two thirds from 1990 to 2015 has captured the attention of
high-level leaders.1–5 The UN Commission for Accountability for Women’s and Children’s
Health is a further reminder of intensified interest, along with numerous initiatives from
donor organisations.4,6,7 Global interest in child mortality reduction is not new; the child
survival revolution,8 Jim Grant’s pioneering work at UNICEF on child interventions,9 and
the Health for All by the Year 2000 campaign10 are examples of the worldwide focus on
improvement of child survival that began more than three decades ago. Key actors such as
the governments of the USA, Ethiopia, and India, together with UNICEF, are arguing for a
continued post-2015 focus on further reductions in child mortality to eliminate all child
deaths from preventable causes by 2035.1 This global goal is mainly motivated, not only by
the huge disparities between and within nations in child mortality, but also by compelling
evidence that child mortality can be reduced even in low-resource settings.11,12
Child mortality worldwide is decreasing and has been in many countries for many
decades.1,13–20 The decreases achieved in high-income, middle-income, and low-income
countries surely count among the more important achievements for humanity in the past 60
years.21–27 Four types of interconnected explanations have been suggested for the sustained
but heterogeneous decrease in child mortality. Demographers and other social scientists
have identified long-term associations between child mortality and maternal education,
income per person, and technology change.28–32 Health-system researchers have explained
why some health systems are able to achieve faster rates of decrease or lower levels of child
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mortality at similar amounts of income and health expenditure than are others.33 More
recently, detailed analyses by the Countdown to 2015 and other groups have sought to
explain levels and trends in child mortality through the coverage of a short list of proven
technologies.5,34 Political scientists have called attention to the potential role of global
collective action, such as the Millennium Declaration itself, as a key contributor to social
phenomenon and health development.35,36 All of these explanations have merit;
understanding the balance and interconnection between them might provide important
insights for future global and national action to accelerate decreases in child mortality.
Timely, local, and valid assessments of trends in child mortality along with the associated
drivers of these trends can provide an important input to national, regional, and global
debates on next steps. Although the long-term trend in child mortality has been downward,
important heterogeneity exists across countries and age groups. Understanding this
heterogeneity can help to catalyse and optimise a process of shared learning from success
stories and to identify crucial areas that need more attention.
Here, we aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors
Study 2013 (GBD 2013) to assess levels and trends of child mortality, and to explore key
factors associated with progress. We aimed to use the GBD 2013 data to report three
interrelated themes: estimate the levels and trends in early neonatal (age 0–6 days), late
neonatal (7–28 days), postneonatal (29–364 days), childhood (1–4 years), and under-5 (0–4
years) mortality from 1990 to 2013, for 188 countries (with one additional country
comparing to GBD 201037 because we included Sudan and South Sudan in this analysis)
with the most up-to-date data and methods; explore the contribution of broad drivers of child
mortality during the past few decades and whether accelerated reductions have been beyond
what might have been expected after 2000; and forecast child mortality to 2030 to identify
populations that are likely to be the main challenges to further global progress with child
survival strategies in the mid-term.
Methods
Estimation of child, infant, and neonatal mortality by country during 1990–2013
We used the broad data analysis strategy from the Global Burden of Diseases, Injuries, and
Risk Factors Study 2010 (GBD 2010) to measure national trends in child mortality. The
appendix summarises the methods we used,13,14,18 including further refinements on the
basis of feedback for GBD 2010. Figure 1 shows the analytical steps we used to estimate
under-5 mortality. This process had three components. First, we used improved formal
demographic methods to analyse empirical data for child deaths reported from censuses,
vital registration systems, sample registration systems, disease surveillance systems, and
various surveys with different birth history modules. Demographic techniques applied to
major sources of data collectively generated more than 29 000 child mortality point
estimates for countries in various years given that there might be multiple mortality
estimates from different sources for a specific country in a given year. Next, we synthesised
child mortality data for each country following a three-step process. First, we applied a non-
linear mixed effects model to examine the relationship between child mortality, lagged
distributed income per person, maternal education, and the crude death rate from HIV/AIDS
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in the under-5 age group. In the second stage, we applied spatiotemporal regression to the
residuals from the first stage regression in which we effectively borrowed strength over time
and across countries within the same GBD region. Results from the second step were then
used as priors in the third stage in which we applied a Gaussian process regression to
generate best estimates of child mortality with 95% uncertainty intervals. In the final
component, we applied an age and sex model to estimate age-specific and sex-specific
mortality for early neonatal, late neonatal, postneonatal, and childhood age groups. The age
and sex model improves upon the GBD 201018 by applying a mixed effects model that
accounts for the differential effect of the HIV/AIDS epidemic on age-specific mortality
among the neonatal age groups and postneonatal deaths under age 5. The appendix provides
details of each component, data, estimates for under-5 mortality, and visualisation of model
fits.
Factors associated with child mortality trends
We explored the correlates of child mortality to establish the contribution of different factors
to recent changes in under-5 mortality rates. We estimated the following equation with
mixed effects linear regression
where c is country, y is year, γc is a random effect on country, LDIcy is lagged distributed
income per person38 for country c in year y, maternal educationcy is the average years of
education earned by women in the age group 15 to 49, HIVcy is HIV-related child crude
death rate39,40 as estimated with the improved EPP-Spectrum for GBD 2013,40–42 and 5q0 is
the probability of death before the age of 5 estimated from this study. We also added
combined year and GBD super-region fixed effects, year_GBD super region, to capture the
differential secular trends of child mortality by geographic units. Following Preston,32 we
used time (year) as a proxy for changes in availability and use of technologies designed to
improve child health that are correlated with time. We used the term “secular trend” to more
broadly encompass the availability of specific child health technologies and changes in our
understanding of how to more effectively deliver health interventions, and the interaction of
health programmes with other technological change such as the expansion of roads or other
related infrastructure.
We tested alternative model specifications including within and between estimators with
different autoregressive terms,43 country fixed effects, and mixed effects models; the
general magnitude of the effects for income, education, and time were robust to
specification. We used this specification because it is the simplest to explain, and we
recorded no qualitative difference in our results across model specifications. We applied
Shapley decomposition44,45 to quantify the contribution of changes in income per person,
maternal education, HIV, secular trend, births, and a collective of “other” factors to the
change in under-5 mortality from 1990 to 2013. Shapley decomposition is a method with a
game theory foundation that allows for decomposition of changes in a variable because of
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different contributory factors. Specifically, to assess the effect of these six factors on
changes in under-5 deaths from 1990 to 2013, we constructed 64 scenarios in which all six
factors took on values from either 1990 or 2013 in each specific scenario.
To compute the effect of any one factor, we assessed 32 pairs of scenarios in which all five
remaining factors had the same values. For each pair, we then calculated the change in
under-5 deaths, for which only the factor of interest changed value, and used this as a
measure of the contribution of this specific factor to the change in under-5 deaths. The
average of the changes in all 32 pairs of scenarios was the contribution of one factor. We
repeated the same process for all six factors.
We used the above equation to predict annualised rates of change for each country from
2000 to 2013 with recorded changes in income per person and maternal education and
counterfactual levels of HIV in the absence of intervention. We generated counterfactual
HIV death rates with the improved EPP-Spectrum models for GBD 201339,40 by setting
prevention of mother-to-child transmission, co-trimoxazole prophylaxis, and antiretroviral
therapy (ART) to zero for all years. These predicted rates provided an estimate of the effect
of changes in income per person, education, and the long-term secular trend by GBD super-
region on the basis of a comparison with observed rates of change.
Scenarios for under-5 mortality in 2030
We developed four scenarios to predict the under-5 mortality rate in 2030 on the basis of the
distribution of observed annualised rates of change from 2000 to 2013. Scenario one used
the observed rate of change from 2000 to 2013 for each country to project to 2030. We
assumed child mortality rates in any country with an increase in mortality in this time stayed
at a constant level during the projection period. In scenario two, we applied the best 75th
percentile rate of change in all countries from 2000 to 2013. In scenario three, all countries
had a rate of change corresponding to the best 90th percentile, and in scenario four, to the
best 95th percentile rate of change. We used observed rates of change for all-cause mortality
by detailed age groups (early neonatal, late neonatal, postneonatal, and childhood deaths at
age 1–4 years) to generate scenarios for the age composition of under-5 deaths. Our
predictions of the number of deaths were based on these predicted rates and UN Population
Division fertility forecasts.46 We then rescaled predicted age-specific and sex-specific
mortality to match the predicted all-cause under-5 mortality rate in 2030. For analyses, we
used Stata (version 13.1), R (versions 2.15.2, 3.0.1, and 3.0.2), and Python (version 2.7.3).
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data
interpretation, or writing of the report. The corresponding author had full access to all the
data in the study and had final responsibility for the decision to submit for publication.
Results
Figure 2 shows the trend in global under-5 mortality rates and the annualised rate of change
in the years from 1970 to 2013. Worldwide, under-5 mortality decreased by slightly more
than two-thirds from 143 per 1000 livebirths in 1970, to 85 per 1000 in 1990, and to 44 per
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1000 in 2013. The global number of under-5 deaths fell from 17·6 million in 1970, to 12·2
million in 1990, and to 6·3 million in 2013. Child mortality fell at an annual rate of between
2·5% and 3·0% from 1970 until 1985, but slowed beginning in 1985, and was at its lowest
(−1·2%) in 1994. Progress in reduction of child mortality accelerated after 1997. Since 2003,
the global child mortality rate has decreased at a faster rate than in the 1970s and 1980s.
Tables 1 and 2 show early neonatal, late neonatal, postneonatal, childhood, and under-5
mortality rates and number of deaths for 1970, 1980, 1990, 2000, and 2013. In 2013, 31·9%
of under-5 deaths worldwide happened in the early neonatal period, 9·7% in the late
neonatal period, 29·4% in the postneonatal period, and 28·9% between the ages of 1–4 years.
The age composition of global child deaths has progressively changed during the past 43
years; the proportion of child deaths in the neonatal (early and late) period increased from
33·4% in 1970, to 37·4% 1990, and to 41·6% in 2013. Annual rates of change between 1970
and 2013 have been very similar (close to −3%) for late neonatal, postneonatal, and ages 1–4
years, but slower (−1·9%) for the early neonatal period (data not shown). Between 2000 and
2013, the annualised rate of change for the early neonatal period was 1·2 to 1·4 percentage
points slower than for other under-5 age-groups, albeit faster than the early neonatal rate of
decline in previous decades. We used the following equation to calculate rate of change
where Rt is the rate in time t and R0 is the rate in time 0, or the baseline. The appendix
shows trends and annualised rates of change for super-regions.
Table 3 provides estimates and uncertainty intervals for early neonatal, late neonatal,
postneonatal, childhood, and under-5 mortality rates by country, and under-5 deaths for
2013, and the annualised rates of change in under-5 mortality rate from 1990 to 2000, 2000
to 2013, and 1990 to 2013 for 188 countries and 21 GBD regions. Under-5 mortality rates
ranged by 66·3 times, from 152·5 per 1000 livebirths in Guinea-Bissau to 2·3 per 1000 in
Singapore in 2013. The ten countries with the highest under-5 mortality rate in 2013 were all
in sub-Saharan Africa. 55 countries achieved under-5 mortality rates lower than 10 per 1000
livebirths in 2013; nine of them were developing countries. In 2013, 26 countries accounted
for 80% of child deaths worldwide (Afghanistan, Angola, Bangladesh, Brazil, Burkina Faso,
Cameroon, Chad, China, Cote d’Ivoire, Democratic Republic of the Congo, Ethiopia,
Ghana, India, Indonesia, Kenya, Malawi, Mali, Mozambique, Niger, Nigeria, Pakistan,
Philippines, Somalia, Sudan, Tanzania, and Uganda; table 3). Neonatal mortality rates
ranged from 42·6 per 1000 in Mali to 1·2 per 1000 in Singapore in 2013 (data not shown).
On the basis of rates of change from 1990 to 2013, 27 of 138 developing countries are likely
to achieve the MDG 4 target of a two-thirds reduction in child mortality from 1990 levels by
2015 (Armenia, Bahrain, Bangladesh, Benin, Bhutan, Brazil, Burma, China, Egypt, El
Salvador, Federated States of Micronesia, Iran, Lebanon, Liberia, Libya, Maldives, Nepal,
Nicaragua, Oman, Peru, Saudi Arabia, Sri Lanka, Thailand, Timor-Leste, Tunisia, Turkey,
and United Arab Emirates).
Figure 3 compares annualised rates of change from 2000 to 2013, with 1990 to 2000. 99 of
188 countries had faster rates of decline between 2000 and 2013 than between 1990 and
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2000. Of note, 90% (43 of 48) of countries in sub-Saharan Africa had a faster rate of
decline. 20 of 29 countries in central Europe, eastern Europe, and central Asia have also had
accelerated decreases. Conversely, 23 of 29 countries in Latin America and the Caribbean
had slower rates of decline after 2000 than before. Additionally, we recorded slower rates of
change in ten regions. Large differences in the rate of change of child mortality were
apparent in several small island nations, most likely due to large random fluctuations over
time.
Since 2000 in sub-Saharan Africa, child mortality has decreased fastest where it increased in
the 1990s (probably because of the HIV epidemic) and then subsequently fell with the scale-
up of prevention of mother-to-child transmission and ART.47–52 Bangladesh has maintained
a consistently higher rate of change of around −4·7% to −5·5% since 1990, slightly higher
than in neighbouring India (−3·0% to −4·3%), although the pace of child mortality change in
India has improved during the past 13 years, reaching −4·5% from 2012 to 2013. Timor-
Leste had one of the fastest rates of change (−7·9% per year) since 2000. Nine countries
accounted for two-thirds of the global decrease of 3·1 million child deaths in 2013 compared
with 2000 (in order of magnitude): India, China, Ethiopia, Bangladesh, Indonesia, Pakistan,
Brazil, Afghanistan, and Nigeria (table 3).
Table 4 shows results for the four regression model specifications that assessed the broad
determinants of change in under-5 mortality. These models account for a very large share of
the recorded variation in under-5 mortality; R2 values ranged from 0·85 to 0·97. For the
mixed effects regression model, the effect of a 10% increase in income per person
corresponded with a 1·6% decrease in under-5 mortality rates. A 1 year increase in maternal
education corresponded with an 8·5% decrease in under-5 mortality rate. Therefore, our
findings confirm and quantify the findings of other researchers that show that improved
levels of maternal education in low-income and middle-income countries have a far greater
effect on reduction of child mortality than do any other intervention.28–32 The year fixed
effects for each super-region that captured the secular trend unobserved by income, maternal
education, or HIV were essentially linear for all regions, although the slope and level of
these regional time trends were quite heterogeneous across regions (data not shown). The
average annual change explained by the secular trend was −2·3% overall, ranging from
−0·4% to −5·4% across regions.
We estimated the contribution of changes in income, education, birth numbers, secular
trend, HIV, and other (unobserved) factors to changes in the number of child deaths in each
country, comparing 1990 with 2013. Worldwide, higher numbers of births contributed to
1·42 million (95% UI 1·41 million–1·44 million) more child deaths in 2013 compared with
in 1990. Similarly, the HIV/AIDS epidemic has resulted in a 32 400 (29 600–35 200)
increase in under-5 deaths from 1990 to 2013 (table 5). Conversely, increased income,
especially after 2000, led to 902 100 (821 100–983 300) fewer deaths in 2013, whereas
improved maternal education led to 2·2 million (2·0 million–2·4 million) fewer deaths. The
secular trend, which we posit to likely represent technological changes and their diffusion,
accounted for 4·2 million (3·5 million–4·8 million) fewer deaths in 2013 than in 1990.
Changes in other factors not accounted for in this simple model led to an increase of 57 800
(−555 900–662 700) deaths in 2013 compared with 1990.
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Figure 4 provides the results of the Shapley decomposition of changes in under-5 deaths for
the seven GBD super-regions. We noted the largest decrease in the number of under-5
deaths in south Asia where the secular shift contributed the most, followed by maternal
education, and then income. Other factors actually led to an increase in the number of child
deaths—ie, south Asia has had less progress than expected in reduction of child deaths
because of unobserved other factors. Child deaths in southeast Asia, east Asia, and Oceania
have also decreased, with most factors except HIV making important contributions to
observed changes (figure 4). In sub-Saharan Africa, increasing birth numbers in the absence
of other change would have led to an increase in under-5 deaths. The main contributors to
lower child mortality were secular factors and maternal education. Table 5 shows more
detail on the Shapley decomposition of changes in the number of under-5 deaths for the 21
GBD regions.
To quantify the potential contribution of global and national action after the Millennium
Declaration on trends in under-5 mortality, figure 5 shows which countries had a much
faster rate of decline than expected. Expected trends are based on recorded income per
person, maternal education, secular trends, and HIV child death rates in the absence of
intervention (ie, what would happen without the global effort in scaling up ART and
prevention of mother-to-child transmission). 14 countries in sub-Saharan Africa (Burundi,
Benin, Burkina Faso, Congo, Ethiopia, Guinea, Liberia, Mozambique, Niger, Rwanda,
Senegal, Sao Tome and Principe, South Africa, and Zambia) had faster than expected
decreases (figure 5). Child mortality decreased faster than predicted in Asia and Europe
(China, Estonia, Cambodia, Laos, Lithuania, Maldives, Montenegro, North Korea, and
Timor-Leste) and in seven countries in Latin America (Bolivia, Brazil, Guatemala,
Nicaragua, Peru, El Salvador, and Venezuela). Countries with slower than expected
decreases include five in Africa and four in Central Asia, and Pakistan (figure 5).
Figure 6 shows possible global trends in under-5 mortality from 2013 to 2030 on the basis of
the four scenarios for change in child mortality rate. Even under the most ambitious scenario
for reduction of child mortality, the number of child deaths worldwide in 2030 would still be
about 2·4 million, roughly 4 million less than the present number, but still substantial. If the
present rates of change continue, 3·8 million children could be expected to die in 2030.
These scenarios assume the UN Population Division forecasts of fertility; faster rates of
fertility decrease than projected by the UN, which might be achieved through scale-up of
family planning services, are not factored into these scenarios, but would lead to fewer
deaths. Figure 7 shows the expected level of child mortality worldwide in 2030 if rates of
change continue as presently recorded. Under this scenario, several countries would still be
expected to have high levels of under-5 mortality in 2030. Under-5 mortality higher than
100 per 1000 livebirths would still prevail in the Central African Republic, Guinea-Bissau,
and Chad; those with expected mortality greater than 70 per 1000 livebirths include Nigeria,
Democratic Republic of the Congo, and Mali (figure 7). Our projections suggest that the
global age composition of under-5 deaths would continue to shift towards a younger
structure. In 2013, neonatal deaths accounted for 41·6% of under-5 deaths worldwide. If
decreases in child mortality do not accelerate, neonatal deaths would account for 44·9% in
2030, by which time postneonatal deaths and those at ages 1–4 years would account, for
28·1% and 26·9%, respectively, of under-5 deaths worldwide.
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Discussion
The dominant global health focus on improvement of child survival in the past four decades
has been extremely successful, although more remains to be done. Child mortality levels
decreased, on average, by 2·6% per year from 1970 to 1985, then slowed down for a decade
until 1997, began to accelerate, and since 2005, have fallen by an average of 3·6% per year.
Accelerated decreases have been recorded in India, nearly all countries in sub-Saharan
Africa, and eastern Europe. Conversely, the rate of decline in child mortality has slowed
down in many Latin America countries (appendix). As a result, 45 (27 of which are
developing) countries are expected to achieve the MDG 4 target rate of 4·4% per year by
2015. The annual number of under-5 deaths has decreased by about two-thirds since 1970,
falling below 7 million for the first time in 2010 and, on the basis of patterns of change since
2000, should reach 5 million by 2021, and 4 million by 2028. If present trends continue,
more than 120 countries would be expected to have child mortality levels lower than 20 per
1000 livebirths in 2030. By our projection, 19 countries will have under-5 mortality higher
than 50 per 1000 livebirths in 2030; however, nine countries (Central African Republic,
Chad, Democratic Republic of the Congo, Guinea-Bissau, Lesotho, Mali, Nigeria, Sierra
Leone, and Somalia) would still have under-5 mortality higher than 70 per 1000. Walker and
colleagues53 have projected under-5 mortality rate to 2035 on the basis of observed rate of
change in the coverage of interventions. Data from their analysis suggest that 37 countries
will probably still have child mortality rates higher than 50 per 1000 livebirths in 2035 if
country level trends in coverage continue unchanged.
Our analysis confirms the findings of previous studies that showed that most countries will
not achieve the MDG 4 target. In our view, this should not be the only standard by which
country progress is measured. In fact, many countries have made huge strides since the
declaration of the MDG goals, including Laos, Cambodia, Rwanda, Vietnam, and Ethiopia.
All five countries have been included by The Partnership for Maternal, Newborn and Child
Health in its success factor analysis. 54 By our estimation, the annualised rate of change in
child mortality in these five countries, although not at the MDG4 rate, are about 4·0%–4·3%.
Our data for observed and expected rates of change since the Millennium Declaration
suggest that accelerated decreases in child mortality cannot be explained by income,
education, or the secular trend (including technological interventions) alone. In fact, in 30
developing countries, under-5 mortality has decreased much faster than expected, including
in some southern African countries that had increases in the 1990s related to the HIV
epidemic and that have subsequently benefited from the scale-up of ART and prevention of
mother-to-child transmission. The commendable progress in this group of countries, which
exceeds expectations, might largely be attributable to global action after the MDGs that led
to increased funding for HIV control programmes. In Niger, this action has been carefully
documented.31 Alternatively, accelerated decreases in Cambodia, Timor-Leste, Guatemala,
and El Salvador after the MDGs could be linked both to government policy change and
increased development assistance for health.55 Changes in Turkey and China, both of which
have received little development assistance per person, are more likely to be related to
national policy change and health-system strengthening.56–59 Rudan and colleagues58 have
documented the rapid fall in child mortality in China and findings of analyses by Feng and
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colleagues59 have shown the important role that socioeconomic and health system
determinants have had in the reduction of child mortality in China.
The reasons underlying these faster than expected decreases in child mortality are
undoubtedly multifactorial and complex, and deserve further study, but prominent among
them is surely the introduction of national policies that promote development and increased
access to essential child-care services among the worst off and increased investments in
health and related sectors. The MDG declaration and subsequent political momentum might
have affected the health-investment landscape, stimulating a more effective and
comprehensive response by bilateral donors, the Global Alliance for Vaccines and
Immunisation (GAVI), the US President’s Emergency Plan for AIDS Relief (PEPFAR), The
Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), the World Bank, and
other development partners to ensure the more widespread dissemination of new
technologies and the remarkable progress against HIV. The attention that has been paid to
achievement of the MDGs more broadly, and not merely those directly concerned with
health, has undoubtedly helped with progress in reduction of child mortality by
improvement of broader development indicators such as education, income, and the
environment, all of which are likely to lead to improved child survival. By contrast, 17
countries had rates of change in under-5 mortality much slower than expected. A more
detailed case study analysis of these countries compared with those with faster than expected
decreases could provide further insights into bottlenecks and circumstances that hinder
progress.
Our analysis of long-term trends in child mortality provides some insight into the
comparative contribution of different factors. Worldwide, income growth between 1990 and
2013 accounted for about 15·6% (95% UI 14·2–16·9) of the change in the number of child
deaths. Although correlated (correlation coefficient 0·72) with income, maternal education
had a much larger effect on decreases in child mortality (38·5% [35·5–41·2]) than did
income, a finding that is consistent with previous research, but provides a quantitative
assessment of just how important mothers’ education is in the reduction of child
mortality.31,60–65 These findings reinforce the continued importance of investments in
primary and secondary schooling for girls in particular. Continued high total fertility rates,
especially in western sub-Saharan Africa, have led to increased numbers of births, which, all
other things being equal, has led to nearly 1 million more child deaths in 2013 than in 1990.
Therefore, the renewed focus on contraceptive programmes for low-income countries66–68 is
very timely and a crucial component of national strategies to help countries to reduce the
number of child deaths.
In a series of analyses spanning four decades, Preston and others32,69 have noted an upward
shift of the association between life expectancy, income, and education—ie, the same level
of income and education today is associated with much lower levels of age-specific
mortality and higher life expectancy than before. Investigators attribute this shift associated
with time to the advancement of technology and the diffusion of such advancement;
technology is defined in this case very broadly to encompass both new methods but also new
ways in which societies are organised to deliver programmes and interventions. We find the
same major shift in the association in our analysis of child mortality. The way that the
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secular trend is estimated would also capture systematic improvements in the average
efficiency of societies’ ability to convert improvements in income and education into child
mortality reductions, such as improved efficiency of production. Overall, the secular trend
accounts for the largest share (72·1% 95% UI 60·8–82·1]) of the change in child deaths from
1990 with 2013. New drugs, vaccines, diagnostics, procedures, and public health campaigns
are part of this shift. In the past 23 years, this shift included innovations such as insecticide-
treated bednets, technologies to prevent mother-to-child transmission of HIV, ART,
rotavirus vaccine,70,71 pneumococcal72 and other vaccines, and many other life-saving
technologies. The dominant role of new technologies and more efficient ways of diffusing
them in poor countries emphasises the importance of continued innovation in drugs,
vaccines, public health programmes, and the delivery of health care for continued declines in
under-5 mortality. Our assessment of the comparative role of health technologies in bringing
about the massive decreases in child mortality in the past few decades provides indirect
evidence for donors, researchers, and countries alike of the crucial effect that these
investments have had.
The variation in child mortality around the income and education curve at a given moment
in time has been interpreted as variation in country performance in the production of better
child health,31,73,74 a component of which might be related to health systems. In our study,
we controlled for time invariant differences between countries that might be related to the
environment or other fixed attributes. We noted unobserved factors beyond income,
maternal education, time, HIV, birth and time-invariant country factors accounted for only
about −1·0% (95% UI −9·5 to 11·5) of the global change in under-5 mortality between 1990
and 2013. Although other factors quantitatively have a much greater role in reductions in
child deaths since 1990 than do the unobserved factors, understanding the local policy
factors associated with this unobserved change could provide important insights and
opportunities for shared learning. Nevertheless, the fact that our model can explain 96·7% of
the observed variation in under-5 mortality rates provides strong evidence to support the
continued investment in the main determinants of lower child mortality, namely maternal
education, income growth, and the development and application of new technologies.
Although substantial progress has been made in reduction of child mortality worldwide, our
scenario analysis of projected under-5 mortality in 2030 provides a sobering reminder of the
magnitude of the task ahead. Even if present, rapid decreases in mortality in low-income
countries of sub-Saharan Africa persist, along with decreases recorded elsewhere, almost 3·8
million children will still die before their fifth birthday in 2030, unless the speed of decrease
can be accelerated. Progress is being hindered partly by fertility patterns in which the
fraction of births worldwide is likely to increasingly shift towards sub-Saharan Africa where
mortality rates are highest. This shift in the distribution of births means that global progress
in reducing child mortality, even if every country maintains the same rate of decline, will
slow. The countries that will have the highest rates of child mortality in 2030, on the basis of
present trends are concentrated in west and central Africa. Ambitious goals to reduce
under-5 mortality to 20 per 1000 livebirths as proposed by the USA, Ethiopia, and India will
need to strategically focus on countries in these regions.1 Anticipation of the pace of these
decreases suggests that donors might want to prioritise funding for some countries on the
basis of their probable future under-5 mortality. Conversely, the pace of child mortality
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decrease in some countries (eg, India) is accelerating, such that by 2030, according to our
base scenario, India will have an under-5 mortality rate lower than 25 per 1000 livebirths.
During the past 6 years, many studies have been done of country levels and trends in child
mortality.1,13,14,75–83 Worldwide, the UN and the GBD estimates of the number of child
deaths have largely converged. The appendix shows estimates from UNICEF and
independent academic studies, including the GBD 2010 and this analysis. In their latest
iteration, the UN Inter-agency Group for Child Mortality Estimation (IGME)84 changed
their methods, which resulted in increased mortality estimates for 1990, which has
substantially changed some of the estimates of annualised rates of decrease. The UN has
estimated that high-income countries such as Spain are under-reporting child deaths,
although no direct evidence of under-reporting exists. Overall, the association between their
estimates of the annualised rate of change from 1990 to 2007, published in 2012, and 2013,
is 0·93.83,85 Likewise, the GBD effort has changed some methods such that the association
of the annualised rate of change for the same period is 0·87 between GBD iterations.
However, the uncertainty intervals on annualised rates of change between 2000 and 2010,
generated as part of the GBD collaboration seem to be robust, and do not overlap in only
eight of 188 cases. Continued improvements in methods and data availability, especially for
recent years, make the assessment of trends comparatively unstable. The correlation between
UNICEF annual rates of change from 1990 to 2007, published in 2009, and in 2013, is 0·79.
The correlation between this study and Rajaratnam and colleagues13 is 0·82. Improvements
in methods and data are to be encouraged, but these perhaps surprisingly modest correlations
mean that the public health community should be cautious in over-interpreting trends.
This analysis has many limitations. First, we attempted to explicitly model the non-sampling
error that affects different surveys in each country (panel). This approach avoids estimation
of false trends due to compositional bias in the data available for a given year but depends
on the validity of the estimates of non-sampling error. Unfortunately, external validation of
this process is not possible except in countries with complete vital registration systems, but
most of these countries do not collect summary or complete birth history data. Second, the
trend for the most recent years is a short-term estimate for many countries. Our estimates
might be too high or too low in these cases and the Gaussian process regression
appropriately generates widening uncertainty intervals for them. However, time lags
between data collection and inclusion in our synthesis are shortening for many countries.
For example, we included results from the sample registration system in India to 2012, and
also data for China through to 2013. Third, in our analysis of the factors contributing to
under-5 mortality change in each region, we included country random effects and fixed
effects on year interacted with region. We might have underestimated the contribution of
local policy and health-system organisation if these changes are associated over time within
a region. Fourth, although we systematically searched and identified sources of data for
under-5 mortality, we probably did not identify all data sources. The large set of
collaborators from 100 countries who participated in GBD 2013 has helped to identify new
sources and assess the quality of existing data, but this information base can be expanded in
the future. Fifth, we used the Shapley decomposition method to parse out the contribution of
different factors to changes in under-5 deaths. This method, although computationally
intensive, is intuitive. Although other methods have been proposed to decompose effects of
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different factors on indicators of interest, Shapley value decomposition, to our knowledge, is
most suitable in our application.86,87
The vigorous debate on setting development goals for the post-2015 era is predicated on the
belief that global goal setting and quantitative monitoring can catalyse change. The
acceleration of decreases in under-5 mortality beyond that expected on the basis of income,
education, and the secular trend, especially in some sub-Saharan African countries,
coincides with the MDG era and increased investments in these countries in health and
social development programmes by various donors. As the end of the MDG era approaches,
the global public health community might better serve the needs of countries by focusing on
the accelerated decreases after 2000 reported here, rather than on which countries will
achieve the arbitrary but seemingly useful targets set by the MDGs. Galvanising political
commitment to ensure life-saving technologies are implemented will be crucial. The
essential health intelligence that comes from large global monitoring efforts such as the
GBD study will better focus attention on countries where progress has been disappointing.
The consequences of not doing so—more than 3 million preventable child deaths in 2030—
would be a scathing indictment of the failure of the donor, research, and international
development community to collectively build on the impressive reductions in child mortality
that we have come to expect.
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Panel: Research in context
Continuous efforts have been made in improving child mortality estimation since the
publication of GBD 2010.18 In this study, significant improvements have been made on
several fronts. First, we employed a mixed effects model to adjust non-sampling data
biases with source-type specific fixed effects across all countries and source-specific
random effects within country. We selected one specific data source in each country as
the reference source, calculated the difference in the summed fixed and random effects
between other sources and the reference source, and subtracted this difference from each
non-reference source to adjust for data bias. In the case that multiple sources were
selected as the reference, we took the average value of the selected sources. More than
300 all-cause mortality experts from around the world contributed to the selection of the
reference data sources. Second, we used a non-linear mixed effects model to more
accurately capture the functional form between child mortality rate and other factors
including HIV/AIDS. This has significant implications for the estimation of child
mortality in the most recent time period in which data are sparse and covariates have a
more pronounced effect on final estimates. Third, we improved our mortality estimation
strategy for neonatal deaths. The new strategy we employed accounted for the fact that
few children die from HIV in the neonatal age group, and helps improve our estimated
age distribution of deaths in children under 5.
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Figure 1.
Child mortality estimation process for the Global Burden of Diseases, Injuries, and Risk
Factors Study 2013
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Figure 2. Global under-5 mortality rate and rate of change, 1970–2013
(A) Global under-5 mortality, 1970–2013. (B) Annualised rate of change in global child
mortality, 1970–2013.
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Figure 3. Global annualised rate of change in under-5 mortality rate (%) from 1990–2000, and
2000–13
Solid line shows the equivalence line between the two periods. Dashed lines show the
Millenium Development Goal 4 target rate of 4·4% per year. We excluded North Korea
from the figure because of substantially higher rates of change that distort the scales in the
figure.CHN=China. EST=Estonia. IDN=Indonesia. GUY=Guyana. ETH=Ethiopia.
TLS=Timor-Leste. IND=India. NER=Niger. PAK=Pakistan. NGA=Nigeria.
MNE=Montenegro. ZAF=South Africa. COG=Congo. TON=Tonga. SWZ =Swaziland.
BWA=Botswana. BHS=The Bahamas. MLT=Malta. FJI=Fiji.
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Figure 4. Change in the number of deaths comparing 2013 with 1990
Change due to income per person, maternal education, HIV child death rate, shift in secular
trend, births, and unexplained factors for seven Global Burden of Disease super-regions.
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Figure 5. Countries with statistically significant differences between the observed rate of decline
in under-5 mortality between 2000 and 2013, compared with the expected rate of decline on the
basis of income, education, shift in secular trend, and HIV death rates in the absence of
intervention
ATG=Antigua and Barbuda. LCA=Saint Lucia. VCT=Saint Vincent and the Grenadines.
TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micronesia.
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Figure 6. Projected global under-5 deaths for four scenarios, 2013–30
Scenarios have been defined by the distribution of observed rates of change 2000 to 2013.
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Figure 7. Projected under-5 mortality rate in 2030, on the basis of the observed rate of change
for each country, 2000–13
ATG=Antigua and Barbuda. LCA=Saint Lucia. VCT=Saint Vincent and the Grenadines.
TTO=Trinidad and Tobago. TLS=Timor-Leste. FSM=Federated States of Micronesia.
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Table 1
Global mortality rate (deaths per 1000 livebirths) for early neonatal, late neonatal,
postneonatal, child, and under-5 age groups for 1970, 1980, 1990, 2000, and 2013
1970 1980 1990 2000 2013
Early neonatal (0–6 days) 31·4 (30·0–32·8) 26·7 (25·7–27·7) 22·6 (21·8–23·3) 19·8 (19·2–20·4) 14·0 (13·5–14·6)
Late neonatal (7–28 days) 16·8 (16·3–17·4) 12·8 (12·6–13·1) 9·3 (9·1–9·5) 7·2 (7·1–7·4) 4·4 (4·1–4·6)
Postneonatal (29–364 days) 48·1 (45·1–51·4) 36·5 (34·9–38·2) 27·6 (26·4–28·8) 22·2 (21·3–23·0) 13·2 (12·4–14·1)
Child (1–4 years) 54·1 (49·8–58·7) 38·7 (36·2–41·3) 27·9 (26·1–29·6) 22·1 (20·9–23·3) 13·1 (12·0–14·3)
Under 5 (0–4 years) 142·6 (138·5–146·9) 110·0 (108·1–111·7) 84·6 (83·3–85·9) 69·4 (68·5–70·4) 44·0 (41·9–46·3)
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Table 2
Global number of deaths (thousands) for early neonatal, late neonatal, postneonatal,
child, and under-5 age groups for 1970, 1980, 1990, 2000, and 2013
1970 1980 1990 2000 2013
Early neonatal (0–6 days) 3886·0 (3707·1–4062·4) 3420·8 (3289·8–3553·1) 3256·8 (3148·0–3363·1) 2638·9 (2561·5–2716·4) 2001·4 (1918·4–2084·3)
Late neonatal (7–28 days) 1999·8 (1944·5–2068·3) 1587·4 (1558·6–1616·9) 1307·9 (1283·2–1333·3) 937·0 (918·8–955·4) 610·7 (578·6–646·1)
Postneonatal (29–364 days) 5636·5 (5294·9–6004·9) 4459·7 (4269·7–4655·4) 3853·7 (3695·1–4015·1) 2874·9 (2768·3–2980·8) 1847·8 (1731·1–1969·8)
Childhood (1–4 years) 6088·4 (5598·6–6604·3) 4554·9 (4254·0–4871·4) 3826·8 (3594·8–4066·9) 2876·8 (2721·4–3040·9) 1816·0 (1654·1–1985·1)
Under 5 (0–4 years) 17597·8 (17119·3–18099·4) 14012·4 (13782·5–14227·7) 12206·3 (12026·1–12384·0) 9327·6 (9206·8–9455·7) 6274·8 (5976·8–6593·4)
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Table 3
Early neonatal, late neonatal, postneonatal, childhood, and under–5 mortality rate and
under–5 deaths in 2013, and annualised rates of change in mortality rates for 1990–2000,
2000–2013, and 1990–2013 for 188 countries and 21 Global Burden of Disease regions
Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
Global 14·0
(13·5 to
14·6)
4·4 (4·1
to 4·6)
13·2
(12·4 to
14·1)
13·1 (12·0 to 14·3) 44·0
(41·9
to
46·3)
6274·8
(5976·8 to
6593·4)
−2·0 (−1·8
to −2·1)
−3·5
(−3·1 to
−3·9)
−2·8
(−2·6 to
−3·1)
High–income Asia Pacific 1·0 (0·8
to 1·2)
0·4 (0·4
to 0·5)
0·9 (0·8
to 1·1)
0·8 (0·7 to 1·1) 3·2 (2·7
to 3·8)
5·1 (4·4 to
6·1)
−3·0 (−2·0
to −4·2)
−4·0
(−2·7 to
−5·2)
−3·6
(−2·6 to
−4·4)
 Brunei 2·7 (2·1
to 3·4)
0·9 (0·8
to 1·0)
2·2 (1·6
to 2·8)
2·5 (1·8 to 3·2) 8·2 (6·8
to
10·0)
0·1 (0·0 to
0·1)
−1·2 (0·0
to −2·2)
−0·8
(1·1 to
−2·4)
−1·0
(0·0 to
−1·8)
 Japan 0·9 (0·7
to 1·2)
0·4 (0·3
to 0·5)
0·9 (0·7
to 1·2)
0·8 (0·6 to 1·1) 3·0 (2·3
to 3·8)
3·2 (2·5 to
4·0)
−2·9 (−2·6
to −3·3)
−3·3
(−1·4 to
−5·1)
−3·2
(−2·1 to
−4·2)
 Singapore 0·8 (0·6
to 1·1)
0·4 (0·3
to 0·4)
0·6 (0·4
to 0·7)
0·5 (0·4 to 0·7) 2·3 (1·8
to 2·9)
0·1 (0·1 to
0·1)
−7·5 (−6·4
to −8·7)
−3·6
(−1·5 to
−5·5)
−5·3
(−4·2 to
−6·4)
 South Korea 1·3 (1·1
to 1·5)
0·5 (0·5
to 0·6)
1·0 (0·9
to 1·2)
0·9 (0·6 to 1·2) 3·7 (3·4
to 4·1)
1·8 (1·6 to
1·9)
−2·9 (−0·5
to −5·5)
−4·9
(−4·2 to
−5·6)
−4·1
(−2·9 to
−5·3)
Central Asia 13·3
(12·5 to
14·1)
3·0 (2·8
to 3·3)
11·1
(10·0 to
12·3)
7·0 (6·1 to 8·1) 34·0
(31·6
to
36·5)
61·9 (57·7
to 66·5)
−1·6 (−1·1
to −2·0)
−3·5
(−2·9 to
−4·1)
−2·7
(−2·3 to
−3·0)
 Armenia 7·3 (6·2
to 8·4)
1·8 (1·6
to 2·0)
4·6 (3·7
to 5·4)
3·2 (2·3 to 4·4) 16·8
(15·2
to
18·7)
0·7 (0·6 to
0·8)
−4·2 (−3·2
to −5·1)
−4·9
(−4·0 to
−5·9)
−4·6
(−4·0 to
−5·1)
 Azerbaijan 14·5
(13·4 to
15·8)
3·4 (3·0
to 3·8)
12·5
(10·5 to
14·9)
5·1 (37 to 6·9) 35·1
(31·8
to
39·0)
5·9 (5·3 to
6·5)
−2·0 (−1·1
to −3·1)
−4·6
(−3·6 to
−5·4)
−3·5
(−2·9 to
−4·0)
 Georgia 9·4 (8·3
to 10·6)
2·0 (1·9
to 2·2)
5·8 (4·8
to 6·9)
4·0 (2·7 to 5·6) 21·1
(19·0
to
23·4)
1·2 (1·1 to
1·4)
−1·3 (0·0
to −2·4)
−4·0
(−2·9 to
−5·2)
−2·8
(−2·2 to
−3·4)
 Kazakhstan 9·8 (8·6
to 11·0)
2·0 (1·9
to 2·2)
6·1 (5·1
to 7·3)
5·1 (3·9 to 6·6) 22·8
(20·6
to
25·3)
7·7 (7·0 to
8·6)
−1·1 (0·0
to −2·3)
−3·5
(−2·4 to
−4·5)
−2·4
(−1·9 to
−3·0)
 Kyrgyzstan 14·5
(13·3 to
15·6)
2·2 (2·0
to 2·4)
9·1 (7·8
to 10·5)
4·1 (3·1 to 5·4) 29·6
(27·0
to 3·2)
4·4 (4·0 to
4·8)
−3·8 (−2·7
to −4·7)
−3·9
(−3·0 to
−4·9)
−3·9
(−3·4 to
−4·3)
 Mongolia 15·1
(13·8 to
16·3)
3 (3·3 to
4·1·1
1 (12·3
to
17·4·47
10·0 (7·4 to 13·3) 42·9
(38·8
to
47·5)
2·7 (2·5 to
3·0)
−4·0 (−3·0
to −4·9)
−3·2
(−2·1 to
−4·1)
−3·5
(−3·0 to
−4·0)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Tajikistan 14·4
(13·0 to
15·5)
3·3 (2·9
to 3·6)
16·1
(13·7 to
18·4)
8·6 (6·3 to 11·6) 4 (37·9
to
45·2·17
11·1 (10·1
to 12·1)
−2·5 (−1·6
to −3·3)
−4·4
(−3·6 to
−5·3)
−3·6
(−3·1 to
−4·0)
 Turkmenistan 17·5
(16·0 to
19·0)
4 (4·1 to
5·4·7
19·6
(15·9 to
2·3)
11·5 (8·2 to 15·9) 5 (46·7
to
58·9)23
5·8 (5·2 to
6·6)
−2·1 (−0·8
to −3·4)
−3·3
(−2·1 to
−4·3)
−2·8
(−2·2 to
−3·4)
 Uzbekistan 14·0
(12·5 to
15·5)
3·4 (3·0
to 3·8)
10·9 (9·0
to 13·1)
8·1 (6·2 to 10·3) 3 (32·5
to
39·9)59
22·3 (20·2
to 24·8)
−0·9 (0·0
to −1·8)
−2·6
(−1·7 to
−3·7)
−1·9
(−1·4 to
−2·4)
East Asia 4·9 (4·3
to 5·5)
1·4 (1·3
to 1·6)
3·5 (2·9
to 4·1)
3·3 (2·4 to 4·2) 13·0
(12·1
to
13·8)
274 (297 to
25·2)
−4·7 (−3·9
to −5·5)
−7·9
(−7·3 to
−8·6)
−6·5
(−6·1 to
−6·9)
 China 4·9 (4·3
to 5·5)
1·4 (1·3
to 1·6)
3·5 (2·9
to 4·1)
3·2 (2·3 to 4·2) 13·0
(12·0
to
13·8)
238 (220·9
to 256·0)
−4·7 (−3·9
to −5·5)
−8·1
(−7·4 to
−8·7)
−6·6
(−6·2 to
−7·0)
 North Korea 8·8 (6·8
to 10·9)
2·0 (1·7
to 2·3)
5·5 (3·9
to 7·5)
5·1 (3·5 to 7·2) 21·2
(17·2
to
26·3)
7·6 (6·1 to
9·4)
−2·1 (−0·1
to −4·0)
−5·7
(−3·9 to
−7·5)
−4·1
(−2·9 to
−5·4)
 Taiwan (Province of
China)
2·1 (1·8
to 2·3)
0·8 (07
to 0·8)
1 (1·4 to
2·0·7
2·2 (1·7 to 2·8) 6·7 (6·1
to 7·3)
1·0 (0·9 to
1·1)
−0·2 (0·2
to −0·6)
−1·8
(−1·1 to
−2·5)
−1·1
(−0·7 to
−1·5)
South Asia 22·5
(21·0 to
24·1)
6·4 (57
to 7·2)
14·2
(12·7 to
16·2)
10·5 (8·7 to 12·9) 52·6
(48·3
to
50·0)
1844·0
(1694·2 to
2031·5)
−2·9 (−2·7
to −3·2)
−3·9
(−3·2 to
−4·6)
−3·5
(−3·1 to
−3·9)
 Afghanistan 20·9
(18·7 to
23·1)
10·7 (9·5
to 12·1)
34·9
(28·0 to
41·9)
26·7 (19·3 to 35·2) 90·2
(81·6
to
100·0)
94·7 (85·6
to 105·2)
−1·7 (−0·9
to −2·5)
−3·6
(−2·6 to
−4·4)
−2·7
(−2·2 to
−3·3)
 Bangladesh 19·3
(17·6 to
21·1)
5·4 (4·8
to 6·2)
9·0 (7·5
to 10·8)
7·6 (5·8 to 9·8) 40·8
(36·9
to
45·4)
128·2
(116·0 to
112·7)
−4·7 (−4·3
to −5·1)
−5·6
(−4·7 to
−6·4)
−5·2
(−4·7 to
−5·6)
 Bhutan 18·9
(16·8 to
21·3)
5·7 (4·6
to 7·0)
14·4
(10·7 to
18·7)
9·3 (6·3 to 14·3) 47·5
(39·9
to
57·0)
0·7 (0·6 to
0·8)
−4·1 (−3·2
to −5·0)
−4·9
(−3·6 to
−6·1)
−4·5
(−3·7 to
−5·3)
 India 22·4
(20·4 to
24·5)
5·7 (4·9
to 6·8)
12·0
(10·0 to
14·6)
9·6 (7·1 to 12·9) 48·8
(43·1
to
56·4)
1249·7
(1103·8 to
1443·7)
−3·0 (−2·7
to −3·4)
−4·3
(−3·2 to
−5·1)
−3·7
(−3·1 to
−4·3)
 Nepal 17·7
(16.1 to
19·4)
4·3 (3·8
to 5·0)
9·2 (7·6
to 11·2)
7·0 (5·2 to 9·1) 37·7
(33·9
to
42·1)
22·2 (20·0
to 24·9)
−5·4 (−5·0
to −5·9)
−6·1
(−5·2 to
−6·9)
−5·8
(−5·3 to
−6·3)
 Pakistan 26·3
(24·2 to
28·6)
10·2 (9·3
to 11·3)
26·5
(22·8 to
3·7)
14·9 (11·1 to 19·4) 75·8
(70·1
to
82·5)
348·5
(321·9 to
379·2)
−1·4 (−1·1
to −1·9)
−1·8
(−1·1 to
−2·5)
−1·7
(−1·3 to
−2·1)
Southeast Asia 9·8 (8·9
to 10·6)
3·2 (2·9
to 3·5)
7·9 (6·8
to 9·2)
6·6 (5·5 to 7·9) 27·2
(24·5
320·9
(289·3 to
358·5)
−4·1 (−3·7
to −4·6)
−4·0
(−3·1 to
−4·8)
−4·0
(−3·5 to
−4·5)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
to
30·4)
 Burma 14·3
(12·7 to
16·1)
3·9 (3·2
to 4·7)
11·1 (8·4
to 14·6)
8·3 (5·6 to 11·8) 37·1
(31·6
to
43·7)
34·1 (29·0
to 40·2)
−3·5 (−1·6
to −5·6)
−5·5
(−3·7 to
−7·1)
−4·6
(−3·7 to
−5·5)
 Cambodia 15·5
(14·0 to
17·1)
4·8 (4·1
to 5·6)
15·6
(12·4 to
19·0)
7·9 (5·6 to 10·5) 43·2
(37·4
to
49·5)
16·7 (14·4
to 19·2)
−1·4 (−0·6
to −2·1)
−6·6
(−5·3 to
−7·7)
−4·3
(−3·6 to
−5·0)
 Indonesia 11·1 (9·9
to 12·3)
3·8 (3·4
to 4·3)
10·0 (8·2
to 12·3)
7·0 (5·2 to 9·0) 31·5
(28·1
to
35·6)
148·8
(132·2 to
168·2)
−4·7 (−4·1
to −5·3)
−4·1
(−3·1 to
−5·1)
−4·4
(−3·8 to
−4·9)
 Laos 18·6
(16·6 to
20·7)
6·7 (5·6
to 7·8)
20·6
(16·2 to
25·5)
16·7 (11·8 to 23·8) 61·3
(52·8
to
69·4)
11·1 (9·5 to
12·6)
−2·6 (−1·5
to −3·8)
−5·3
(−4·1 to
−6·6)
−4·1
(−3·5 to
−4·9)
 Malaysia 2·3 (1·9
to 2·7)
1·0 (0·9
to 1·1)
1·6 (1·3
to 2·1)
1·6 (1·2 to 2·1) 6·5 (5·5
to 7·6)
3·3 (2·9 to
4·0)
−6·1 (−5·8
to −6·4)
−2·7
(−1·3 to
−3·8)
−4·2
(−3·4 to
−4·8)
 Maldives 8·0 (6·4
to 10·1)
1·9 (1·7
to 2·1)
2·9 (2·4
to 3·5)
3·6 (2·7 to 4·7) 16·3
(13·5
to
19·7)
0·1 (0·1 to
0·1)
−6·1 (−4·8
to −7·3)
−6·7
(−5·1 to
−8·2)
−6·5
(−5·6 to
−7·2)
 Philippines 9·9 (8·4
to 11·3)
2·6 (2·3
to 3·0)
6·9 (5·4
to 8·9)
8·2 (6·2 to 10·7) 27·3
(23·2
to
32·2)
65·1 (55·4
to 76·9)
−3·3 (−2·3
to −4·3)
−2·7
(−1·3 to
−4·2)
−3·0
(−2·2 to
−3·7)
 Sri Lanka 3·2 (2·6
to 3·8)
1·3 (1·2
to 1·5)
1·9 (1·5
to 2·3)
2·5 (1·8 to 3·2) 8·8 (7·5
to
10·5)
3·4 (2·8 to
4·0)
−8·0 (−7·7
to −8·3)
−4·8
(−3·5 to
−6·1)
−6·2
(−5·4 to
−6·9)
 Thailand 4·6 (3·7
to 5·8)
2·1 (1·8
to 2·4)
2·3 (1·9
to 2·6)
2·1 (1·6 to 2·9) 11·0
(9·3 to
13·2)
7·7 (6·5 to
9·2)
−5·0 (−3·1
to −6·9)
−4·2
(−2·5 to
−5·8)
−4·5
(−3·5 to
−5·4)
 Timor-Leste 13·7
(12·3 to
15·1)
2·4 (2·0
to 2·8)
15·3
(12·2 to
19·1)
7·9 (5·7 to 10·7) 38·8
(33·3
to
45·3)
1·6 (1·3 to
1·8)
−3·4 (−2·6
to −4·1)
−7·9
(−6·6 to
−9·2)
−5·9
(−5·2 to
−6·7)
 Vietnam 6·9 (5·4
to 8·5)
2·6 (2·4
to 2·9)
3·7 (3·0
to 4·6)
5·4 (4·1 to 7·1) 18·6
(15·8
to
21·9)
26·6 (22·6
to 31·5)
−5·0 (−3·7
to −6·2)
−3·4
(−1·9 to
−5·1)
−4·1
(−3·3 to
−4·8)
Australasia 1·8 (1·5
to 2·2)
0·5 (0·4
to 0·6)
1·4 (1·1
to 1·6)
0·9 (0·7 to 1·1) 4·6 (3·9
to 5·4)
1·8 (1·5 to
2·1)
−4·1 (−3·7
to −4·5)
−2·8
(−1·4 to
−4·1)
−3·4
(−2·6 to
−4·1)
 Australia 1·8 (1·5
to 2·2)
0·5 (0·4
to 0·6)
1·2 (1·0
to 1·4)
0·8 (0·6 to 1·1) 4·4 (3·7
to 5·1)
1·3 (1·1 to
1·6)
−4·2 (−3·6
to −4·7)
−2·9
(−1·5 to
−4·1)
−3·4
(−2·7 to
−4·1)
 New Zealand 1·8 (1·5
to 2·2)
0·5 (0·5
to 0·6)
2·1 (1·7
to 2·6)
1·1 (0·8 to 1·5) 5·6 (4·7
to 6·7)
0·3 (0·3 to
0·4)
−4·0 (−3·1
to −4·8)
−2·4
(−0·9 to
−3·8)
−3·1
(−2·3 to
−3·8)
 Caribbean 11·6
(10·1 to
13·6)
4·5 (4·0
to 5·2)
12·0
(10·1 to
14·4)
7·8 (6·0 to 9·9) 35·5
(30·9
29·8 (26·1
to 34·4)
−3·5 (−3·0
to −4·1)
−2·2
(−1·1 to
−3·3)
−2·8
(−2·1 to
−3·4)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
to
41·2)
 Antigua and Barbuda 7·0 (2·8
to 14·4)
2·0 (1·1
to 3·3)
3·8 (1·8
to 8·1)
2·6 (1·1 to 5·7) 15·3
(6·9 to
30·9)
0·0 (0·0 to
0·0)
−0·7 (6·1
to −7·7)
−1·6
(4·9 to
−8·4)
−1·2
(2·8 to
−5·2)
 Barbados 8·1 (3·1
to 16·3)
2·2 (1·3
to 3·9)
4·4 (2·1
to 10·1)
1·8 (0·8 to 3·9) 16·5
(7·3 to
33·5)
0·1 (0·0 to
0·1)
−3·1 (4·4
to −10·2)
−1·7
(5·5 to
−8·8)
−2·3
(1·3 to
−6·0)
 Belize 8·7 (3·7
to 15·6)
2·3 (1·3
to 3·9)
4·6 (2·4
to 10·3)
3·1 (1·4 to 6·3) 18·6
(9·0 to
35·5)
0·1 (0·1 to
0·3)
−3·8 (−1·1
to −6·6)
−3·6
(1·8 to
−9·1)
−3·7
(−0·5 to
−6·7)
 Cuba 2·0 (1·6
to 2·4)
0·9 (0·8
to 1·1)
1·7 (1·3
to 2·0)
1·1 (0·8 to 1·4) 5·7 (4·9
to 6·6)
0·6 (0·5 to
0·7)
−4·9 (−4·4
to −5·3)
−3·1
(−1·9 to
−4·3)
−3·9
(−3·2 to
−4·5)
 Dominica 10·2 (4·3
to 17·5)
2·6 (1·5
to 4·8)
5·6 (2·6
to 13·8)
3·6 (1·7 to 7·9) 21·8
(10·2
to
42·8)
0·0 (0·0 to
0·0)
−2·1 (5·1
to −9·1)
−1·3
(5·4 to
−7·7)
−1·6
(2·7 to
−5·6)
 Dominican Republic 13·6
(11·7 to
15·6)
3·1 (2·6
to 3·8)
7·6 (5·5
to 10·1)
4·6 (3·1 to 6·6) 28·8
(24·1
to
34·5)
6·2 (5·2 to
7·5)
−4·7 (−3·8
to −5·6)
−1·9
(−0·3 to
−3·4)
−3·1
(−2·3 to
−3·9)
 Grenada 5·9 (2·5
to 12·6)
1·8 (1·0
to 2·9)
3·3 (1·5
to 6·7)
2·2 (1·0 to 4·2) 13·2
(6·1 to
25·9)
0·0 (0·0 to
0·1)
−3·2 (3·4
to −10·1)
−3·6
(2·5 to
−9·8)
−3·4
(0·5 to
−7·2)
 Guyana 11·8 (6·8
to 16·8)
3·6 (2·1
to 7·0)
14·0 (5·4
to 29·3)
7·2 (2·8 to 17·3) 36·2
(17·2
to
69·5)
0·6 (0·3 to
1·1)
−4·1 (−2·0
to −6·1)
0·1 (5·7
to −5·4)
−1·7
(1·5 to
−4·7)
 Haiti 16·7
(14·7 to
18·8)
8·8 (7·6
to 10·4)
25·4
(20·6 to
31·4)
16·9 (11·7 to 22·9) 66·1
(56·8
to
77·6)
17·4 (14·9
to 20·5)
−4·0 (−3·3
to −4·8)
−3·0
(−1·8 to
−4·2)
−3·5
(−2·8 to
−4·2)
 Jamaica 7·6 (2·7
to 14·5)
2·0 (1·1
to 3·7)
4·1 (1·9
to 9·9)
4·6 (1·9 to 10·3) 18·3
(8·0 to
37·6)
0·9 (0·4 to
1·9)
−2·8 (1·1
to −7·0)
−2·2
(4·0 to
−8·5)
−2·5
(1·2 to
−6·2)
 Saint Lucia 8·4 (3·3
to 16·2)
2·3 (1·2
to 4·1)
4·6 (2·2
to 10·8)
3·1 (1·3 to 6·6) 18·2
(8·1 to
37·1)
0·1 (0·0 to
0·1)
−5·0 (1·6
to −11·4)
−0·8
(5·9 to
−7·3)
−2·6
(1·6 to
−6·4)
 Saint Vincent and the
Grenadines
10·9 (4·7
to 18·2)
2·7 (1·6
to 5·1)
6·2 (2·9
to 15·1)
3·9 (1·7 to 8·6) 23·6
(11·0
to
46·0)
0·0 (0·0 to
0·1)
−2·8 (4·2
to −10·0)
−2·1
(4·2 to
−7·8)
−2·4
(1·4 to
−6·0)
 Suriname 16·5
(14·4 to
18·6)
4·2 (3·4
to 5·1)
11·4 (8·4
to 15·3)
6·6 (4·3 to 9·4) 38·1
(31·8
to
45·7)
0·4 (0·3 to
0·4)
−1·5 (0·3
to −3·3)
−1·1
(0·7 to
−2·8)
−1·3
(−0·4 to
−2·2)
 The Bahamas 11·3 (4·9
to 22·4)
1·0 (0·6
to 1·7)
2·1 (1·1
to 4·7)
2·1 (0·9 to 4·5) 16·5
(7·5 to
32·6)
0·1 (0·0 to
0·2)
−6·8 (0·2
to −13·0)
−0·6
(5·8 to
−7·4)
−3·3
(0·9 to
−7·2)
 Trinidad and Tobago 11·2 (4·4
to 20·4)
4·0 (2·2
to 7·6)
4·0 (1·9
to 10·8)
3·3 (1·5 to 6·7) 22·3
(9·9 to
45·0)
0·4 (0·2 to
0·9)
0·7 (5·0 to
−3·7)
−2·7
(3·5 to
−9·2)
−1·2
(2·3 to
−4·7)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
Central Europe 2·4 (1·7
to 3·5)
1·0 (0·8
to 1·4)
2·2 (1·6
to 3·1)
1·1 (0·8 to 1·5) 6·7 (4·9
to 9·4)
8·4 (6·1 to
11·8)
−4·9 (−4·5
to −5·4)
−5·1
(−2·4 to
−7·5)
−5·1
(−3·5 to
−6·3)
 Albania 2·7 (1·0
to 4·8)
1·8 (0·9
to 2·8)
8·3 (4·0
to 18·4)
5·2 (2·6 to 10·4) 17·9
(8·6 to
35·1)
0·7 (0·3 to
1·4)
−4·1 (−2·0
to −6·2)
−3·5
(2·3 to
−8·6)
−3·8
(−0·6 to
−6·7)
 Bosnia and Herzegovina 3·1 (2·0
to 4·5)
0·6 (0·5
to 0·8)
1·0 (0·7
to 1·6)
0·7 (0·4 to 1·1) 5·4 (3·6
to 7·9)
0·2 (0·1 to
0·3)
−5·4 (−4·5
to −6·2)
−5·2
(−2·2 to
−8·3)
−5·3
(−3·6 to
−6·9)
 Bulgaria 2·9 (2·0
to 4·5)
1·5 (1·1
to 2·1)
3·6 (2·4
to 4·8)
1·7 (1·1 to 2·6) 9·7 (6·8
to
13·8)
0·7 (0·5 to
1·0)
−0·3 (0·4
to −0·9)
−4·6
(−1·8 to
−7·2)
−2·7
(−1·1 to
−4·2)
 Croatia 2·2 (1·4
to 3·3)
0·7 (0·5
to 0·9)
1·0 (0·7
to 1·5)
0·7 (0·4 to 1·0) 4·6 (3·1
to 6·6)
0·2 (0·1 to
0·3)
−3·3 (−2·1
to −4·4)
−4·9
(−1·8 to
−7·8)
−4·2
(−2·5 to
−5·8)
 Czech Republic 1·0 (0·6
to 1·5)
0·6 (0·4
to 0·8)
0·9 (0·7
to 1·3)
0·5 (0·3 to 0·7) 3·0 (2·1
to 4·3)
0·4 (0·2 to
0·5)
−8·6 (−7·7
to −9·6)
−4·5
(−1·5 to
−7·1)
−6·3
(−4·6 to
−7·8)
 Hungary 2·3 (1·8
to 2·9)
0·9 (0·8
to 1·1)
1·3 (1·0
to 1·6)
0·6 (0·4 to 0·9) 5·1 (4·1
to 6·4)
0·5 (0·4 to
0·6)
−4·8 (−4·1
to −5·4)
−5·5
(−3·8 to
−7·3)
−5·2
(−4·1 to
−6·1)
 Macedonia 3·3 (2·2
to 5·3)
1·4 (1·0
to 1·9)
2·3 (1·5
to 3·4)
0·9 (0·6 to 1·5) 8·0 (5·3
to
11·9)
0·2 (0·1 to
0·3)
−8·1 (−7·2
to −8·9)
−5·2
(−1·9 to
−8·2)
−6·4
(−4·7 to
−8·2)
 Montenegro 2·4 (1·3
to 4·0)
1·0 (0·6
to 1·5)
1·9 (1·1
to 3·2)
1·0 (0·5 to 1·8) 6·3 (3·6
to
10·5)
0·0 (0·0 to
0·1)
−0·1 (6·4
to −6·3)
−9·1
(−5·0 to
−13·0)
−5·2
(−1·7 to
−8·5)
 Poland 2·2 (1·5
to 3·2)
0·9 (0·7
to 1·2)
1·3 (0·9
to 1·9)
0·6 (0·4 to 1·0) 5·0 (3·5
to 7·2)
2·1 (1·4 to
3·0)
−6·4 (−6·1
to −6·8)
−4·9
(−2·0 to
−7·5)
−5·5
(−3·9 to
−7·0)
 Romania 3·2 (1·8
to 6·0)
1·5 (1·0
to 2·2)
4·5 (2·6
to 6·8)
1·9 (1·1 to 3·0) 11·0
(6·6 to
17·7)
2·5 (1·5 to
4·0)
−3·5 (−3·3
to −3·9)
−6·0
(−2·2 to
−9·5)
−4·9
(−2·7 to
−7·0)
 Serbia 2·4 (1·8
to 3·0)
0·7 (0·6
to 0·8)
1·2 (0·9
to 1·5)
0·7 (0·5 to 0·9) 4·9 (3·9
to 6·0)
0·5 (0·4 to
0·6)
−8·9 (−3·2
to −13·9)
−3·3
(−1·7 to
−5·1)
−5·7
(−3·0 to
−8·2)
 Slovakia 2·3 (1·3
to 3·8)
1·1 (0·8
to 1·7)
2·2 (1·2
to 3·6)
1·0 (0·6 to 1·8) 6·7 (4·0
to
10·8)
0·4 (0·2 to
0·6)
−3·2 (−2·3
to −4·1)
−3·4
(0·6 to
−7·0)
−3·3
(−1·0 to
−5·3)
 Slovenia 1·5 (0·8
to 2·6)
0·5 (0·3
to 0·8)
1·0 (0·6
to 1·6)
0·6 (0·3 to 1·1) 3·6 (2·1
to 6·0)
0·1 (0·0 to
0·1)
−5·8 (−3·9
to −7·8)
−3·5
(0·6 to
−7·2)
−4·5
(−2·0 to
−6·7)
Eastern Europe 3·5 (2·6
to 4·7)
1·3 (1·1
to 1·6)
3·0 (2·3
to 3·6)
2·0 (1·5 to 2·6) 9·7 (7·7
to
12·2)
23·6 (18·5
to 29·4)
−1·3 (0·1
to −2·7)
−5·5
(−3·7 to
−7·4)
−3·7
(−2·5 to
−4·9)
 Belarus 2·7 (2·0
to 3·9)
1·1 (0·9
to 1·5)
2·4 (1·6
to 3·4)
1·4 (0·9 to 2·0) 7·6 (5·5
to
10·4)
0·8 (0·6 to
1·1)
−2·3 (1·3
to −5·9)
−5·8
(−2·8 to
−9·0)
−4·3
(−2·4 to
−6·0)
 Estonia 1·4 (1·0
to 1·8)
0·8 (0·6
to 1·0)
1·1 (0·8
to 1·5)
0·9 (0·6 to 1·2) 4·2 (3·4
to 5·2)
0·1 (0·0 to
0·1)
−4·5 (−3·5
to −5·7)
−7·7
(−5·8 to
−9·4)
−6·3
(−5·3 to
−7·3)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Latvia 2·1 (1·7
to 2·5)
1·1 (1·0
to 1·3)
1·8 (1·4
to 2·3)
1·4 (1·0 to 1·8) 6·4 (5·3
to 7·6)
0·1 (0·1 to
0·2)
−2·8 (−1·9
to −3·7)
−5·8
(−4·3 to
−7·4)
−4·5
(−3·7 to
−5·3)
 Lithuania 1·4 (1·1
to 1·8)
0·7 (0·6
to 0·8)
1·5 (1·1
to 1·8)
1·0 (0·7 to 1·3) 4·6 (3·6
to 5·6)
0·2 (0·1 to
0·2)
−2·6 (−1·6
to −3·6)
−6·8
(−5·2 to
−8·7)
−5·0
(−4·0 to
−6·0)
 Moldova 5·3 (3·5
to 7·3)
1·5 (1·1
to 1·9)
3·8 (2·9
to 4·7)
2·2 (1·4 to 3·3) 12·6
(9·2 to
16·4)
0·5 (0·4 to
0·7)
−1·4 (0·7
to −3·5)
−5·8
(−3·3 to
−8·4)
−3·9
(−2·4 to
−5·3)
 Russia 3·4 (2·6
to 4·6)
1·3 (1·1
to 1·6)
2·9 (2·2
to 3·7)
2·0 (1·4 to 2·8) 9·6 (7·5
to
12·1)
16·3 (12·6
to 20·7)
−1·6 (0·7
to −4·1)
−5·5
(−3·7 to
−7·4)
−3·8
(−2·3 to
−5·2)
 Ukraine 4·1 (2·9
to 5·7)
1·5 (1·2
to 1·9)
3·3 (2·5
to 4·2)
2·0 (1·4 to 2·8) 10·9
(8·3 to
13·9)
5·4 (4·1 to
6·9)
0·2 (2·3 to
−1·9)
−5·4
(−3·1 to
−7·9)
−3·0
(−1·7 to
−4·3)
Western Europe 1·6 (1·3
to 2·0)
0·6 (0·5
to 0·7)
1·1 (0·9
to 1·3)
0·7 (0·6 to 0·8) 3·9 (3·3
to 4·7)
18·2 (15·2
to 21·9)
−5·0 (−4·8
to −5·2)
−2·9
(−1·4 to
−4·3)
−3·8
(−3·0 to
−4·6)
 Andorra 1·0 (0·6
to 1·8)
0·4 (0·2
to 0·7)
0·7 (0·4
to 1·2)
0·4 (0·2 to 0·8) 2·6 (1·5
to 4·4)
0·0 (0·0 to
0·0)
−6·4 (−0·6
to −11·4)
−2·9
(1·8 to
−7·3)
−4·5
(−1·4 to
−7·3)
 Austria 1·7 (1·3
to 2·1)
0·6 (0·5
to 0·7)
1·2 (0·9
to 1·5)
0·7 (0·5 to 0·9) 4·1 (3·2
to 5·2)
0·3 (0·3 to
0·4)
−5·6 (−4·8
to −6·6)
−2·3
(−0·4 to
−4·1)
−3·8
(−2·7 to
−4·8)
 Belgium 1·8 (1·5
to 2·1)
0·6 (0·5
to 0·7)
1·2 (1·0
to 1·4)
0·7 (0·5 to 0·9) 4·2 (3·6
to 5·0)
0·5 (0·5 to
0·6)
−5·7 (−5·3
to −6·2)
−2·4
(−1·2 to
−3·7)
−3·9
(−3·1 to
−4·5)
 Cyprus 1·9 (1·4
to 2·4)
0·7 (0·6
to 0·8)
1·2 (1·0
to 1·6)
0·3 (0·2 to 0·4) 4·1 (3·3
to 5·1)
0·0 (0·0 to
0·0)
−6·3 (−5·2
to −7·4)
−2·9
(−0·9 to
−4·7)
−4·4
(−3·3 to
−5·4)
 Denmark 1·7 (1·3
to 2·1)
0·5 (0·4
to 0·6)
1·0 (0·8
to 1·2)
0·7 (0·5 to 0·9) 3·8 (3·0
to 4·8)
0·2 (0·2 to
0·3)
−5·1 (−4·1
to −5·9)
−3·0
(−0·9 to
−4·8)
−3·9
(−2·8 to
−5·0)
 Finland 1·3 (1·0
to 1·8)
0·4 (0·3
to 0·5)
0·7 (0·5
to 0·9)
0·6 (0·4 to 0·8) 3·0 (2·3
to 3·8)
0·2 (0·1 to
0·2)
−5·1 (−4·1
to −6·2)
−2·7
(−0·7 to
−4·4)
−3·7
(−2·6 to
−4·7)
 France 1·3 (1·0
to 1·6)
0·6 (0·5
to 0·7)
1·2 (1·0
to 1·5)
0·7 (0·5 to 0·9) 3·7 (3·1
to 4·6)
3·0 (2·4 to
3·7)
−4·8 (−4·5
to −5·2)
−2·9
(−1·3 to
−4·5)
−3·8
(−2·9 to
−4·6)
 Germany 1·6 (1·3
to 1·8)
0·5 (0·4
to 0·5)
1·0 (0·8
to 1·1)
0·6 (0·5 to 0·8) 3·6 (3·2
to 4·1)
2·5 (2·2 to
2·9)
−5·5 (−5·2
to −5·9)
−3·0
(−1·9 to
−3·9)
−4·1
(−3·5 to
−4·6)
 Greece 1·6 (1·4
to 1·9)
0·9 (0·8
to 1·0)
1·0 (0·9
to 1·2)
0·6 (0·4 to 0·7) 4·0 (3·6
to 4·6)
0·4 (0·4 to
0·5)
−4·9 (−4·5
to −5·4)
−3·5
(−2·5 to
−4·5)
−4·1
(−3·5 to
−4·7)
 Iceland 0·9 (0·6
to 1·4)
0·4 (0·3
to 0·5)
0·7 (0·5
to 1·0)
0·4 (0·2 to 0·6) 2·4 (1·7
to 3·5)
0·0 (0·0 to
0·0)
−5·7 (−3·0
to −8·3)
−3·8
(−0·8 to
−6·6)
−4·6
(−2·8 to
−6·3)
 Ireland 2·0 (1·4
to 2·7)
0·5 (0·4
to 0·7)
1·3 (1·0
to 1·8)
0·8 (0·5 to 1·1) 4·6 (3·4
to 6·1)
0·3 (0·2 to
0·4)
−3·4 (−2·2
to −4·3)
−3·3
(−1·0 to
−5·5)
−3·3
(−2·0 to
−4·5)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Israel 1·6 (1·3
to 2·0)
0·6 (0·6
to 0·7)
1·3 (1·0
to 1·5)
0·8 (0·6 to 1·0) 4·3 (3·7
to 5·0)
0·7 (0·6 to
0·8)
−5·1 (−4·4
to −5·8)
−4·1
(−2·8 to
−5·2)
−4·5
(−3·8 to
−5·1)
 Italy 1·7 (1·3
to 2·3)
0·7 (0·5
to 0·8)
0·8 (0·6
to 1·0)
0·5 (0·4 to 0·7) 3·7 (2·8
to 4·8)
2·1 (1·6 to
2·7)
−5·6 (−5·1
to −5·9)
−3·1
(−1·0 to
−5·2)
−4·2
(−3·0 to
−5·3)
 Luxembourg 1·1 (0·8
to 1·6)
0·4 (0·3
to 0·6)
0·8 (0·6
to 1·1)
0·4 (0·3 to 0·7) 2·8 (2·0
to 3·9)
0·0 (0·0 to
0·0)
−6·2 (−3·9
to −8·4)
−4·6
(−1·9 to
−7·2)
−5·3
(−3·7 to
−6·8)
 Malta 3·2 (2·3
to 4·3)
1·0 (0·8
to 1·2)
2·1 (1·5
to 3·0)
0·7 (0·5 to 1·0) 7·0 (5·1
to 9·5)
0·0 (0·0 to
0·0)
−3·4 (−1·4
to −5·4)
0·0 (2·5
to −2·5)
−1·5
(0·0 to
−2·9)
 Netherlands 1·8 (1·4
to 2·3)
0·5 (0·4
to 0·6)
0·9 (0·7
to 1·2)
0·8 (0·6 to 1·1) 4·1 (3·3
to 5·1)
0·7 (0·6 to
0·9)
−3·2 (−2·5
to −3·8)
−3·6
(−1·9 to
−5·3)
−3·4
(−2·4 to
−4·3)
 Norway 1·2 (0·9
to 1·4)
0·4 (0·3
to 0·4)
0·8 (0·7
to 1·0)
0·6 (0·5 to 0·8) 3·0 (2·5
to 3·6)
0·2 (0·2 to
0·2)
−5·9 (−4·9
to −6·9)
−4·0
(−2·6 to
−5·4)
−4·8
(−4·0 to
−5·6)
 Portugal 1·2 (1·1
to 1·4)
0·5 (0·5
to 0·6)
1·0 (0·9
to 1·2)
0·7 (0·5 to 0·9) 3·5 (3·0
to 4·0)
0·3 (0·3 to
0·4)
−7·1 (−6·7
to −7·5)
−5·6
(−4·6 to
−6·6)
−6·2
(−5·6 to
−6·8)
 Spain 1·3 (1·0
to 1·7)
0·7 (0·6
to 0·8)
1·0 (0·8
to 1·2)
0·6 (0·5 to 0·8) 3·6 (2·9
to 4·4)
1·8 (1·4 to
2·2)
−5·5 (−5·0
to −6·0)
−3·2
(−1·6 to
−4·7)
−4·2
(−3·3 to
−5·1)
 Sweden 1·2 (0·9
to 1·5)
0·3 (0·3
to 0·4)
0·7 (0·6
to 0·9)
0·5 (0·4 to 0·7) 2·7 (2·1
to 3·4)
0·3 (0·2 to
0·4)
−6·2 (−5·3
to −7·1)
−3·0
(−1·1 to
−4·8)
−4·4
(−3·3 to
−5·4)
 Switzerland 2·0 (1·7
to 2·3)
0·5 (0·4
to 0·5)
1·1 (0·9
to 1·3)
0·8 (0·6 to 1·1) 4·3 (3·8
to 5·0)
0·4 (0·3 to
0·4)
−4·0 (−3·5
to −4·5)
−2·1
(−1·0 to
−3·1)
−2·9
(−2·3 to
−3·5)
 UK 2·1 (1·7
to 2·7)
0·7 (0·6
to 0·8)
1·4 (1·1
to 1·7)
0·8 (0·6 to 1·0) 4·9 (4·0
to 6·0)
3·8 (3·1 to
4·7)
−4·1 (−3·8
to −4·5)
−2·0
(−0·4 to
−3·5)
−2·9
(−2·0 to
−3·8)
Andean Latin America 8·5 (7·9
to 9·0)
3·2 (3·1
to 3·4)
10·0 (9·1
to 10·9)
6·8 (5·8 to 7·9) 28·2
(26·9
to
29·6)
34·0 (32·4
to 35·7)
−5·0 (−4·7
to −5·4)
−3·8
(−3·3 to
−4·2)
−4·3
(−4·1 to
−4·6)
 Bolivia 13·1
(12·0 to
14·2)
4·1 (3·8
to 4·4)
15·5
(13·3 to
17·8)
9·9 (7·5 to 12·9) 41·9
(39·0
to
45·2)
11·4 (10·7
to 12·3)
−4·5 (−4·0
to −5·1)
−3·9
(−3·2 to
−4·5)
−4·2
(−3·8 to
−4·5)
 Ecuador 5·6 (5·0
to 6·2)
3·5 (3·3
to 3·7)
11·9
(10·1 to
13·8)
7·8 (6·0 to 9·9) 28·6
(26·6
to
30·9)
9·4 (8·7 to
10·1)
−3·1 (−2·3
to −3·9)
−2·7
(−1·9 to
−3·3)
−2·8
(−2·4 to
−3·2)
 Peru 8·0 (7·1
to 8·9)
2·7 (2·6
to 2·8)
6·6 (5·7
to 7·6)
4·9 (3·7 to 6·3) 22·0
(20·5
to
23·8)
13·2 (12·3
to 14·3)
−6·4 (−5·7
to −6·9)
−4·5
(−3·8 to
−5·1)
−5·3
(−4·9 to
−5·7)
Central Latin America 5·8 (5·2
to 6·4)
2·3 (2·2
to 2·4)
6·0 (5·4
to 6·7)
4·0 (3·5 to 4·5) 18·0
(16·5
to
19·7)
87·7 (80·4
to 96·1)
−4·0 (−3·5
to −4·5)
−3·6
(−2·8 to
−4·4)
−3·8
(−3·3 to
−4·2)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Colombia 5·2 (4·5
to 6·0)
2·2 (2·1
to 2·3)
5·9 (5·1
to 6·8)
4·8 (3·8 to 6·0) 17·9
(16·3
to
19·8)
16·3 (14·9
to 18·0)
−2·3 (−1·5
to −3·2)
−3·1
(−2·3 to
−4·0)
−2·8
(−2·3 to
−3·2)
 Costa Rica 3·9 (3·5
to 4·5)
1·3 (1·2
to 1·4)
3·3 (2·9
to 3·7)
1·9 (1·5 to 2·5) 10·4
(9·5 to
11·5)
0·8 (0·7 to
0·8)
−3·3 (−2·2
to −4·5)
−2·9
(−1·9 to
−3·9)
−3·1
(−2·5 to
−3·6)
 El Salvador 4·6 (3·7
to 5·5)
1·9 (1·7
to 2·1)
4·6 (3·6
to 5·7)
2·4 (1·9 to 3·1) 13·4
(12·2
to
14·8)
1·7 (1·6 to
1·9)
−5·9 (−4·8
to −7·0)
−6·2
(−5·2 to
−7·2)
−6·1
(−5·6 to
−6·6)
 Guatemala 6·5 (5·9
to 7·3)
2·8 (2·6
to 3·0)
10·4 (8·8
to 12·2)
8·6 (6·9 to 10·7) 28·1
(25·5
to
30·9)
13·3 (12·1
to 14·7)
−4·0 (−3·0
to −4·9)
−4·6
(−3·7 to
−5·5)
−4·3
(−3·9 to
−4·8)
 Honduras 9·2 (8·2
to 10·1)
2·6 (2·4
to 2·8)
6·3 (5·3
to 7·2)
5·3 (4·1 to 6·6) 23·1
(21·2
to
25·2)
4·8 (4·4 to
5·2)
−3·9 (−3·1
to −4·7)
−3·6
(−2·8 to
−4·3)
−3·7
(−3·3 to
−4·2)
 Mexico 5·8 (5·1
to 6·6)
2·4 (2·2
to 2·6)
5·6 (4·8
to 6·6)
3·1 (2·3 to 3·8) 16·8
(15·3
to
18·6)
38·1 (34·7
to 42·0)
−4·6 (−3·6
to −5·7)
−3·6
(−2·6 to
−4·5)
−4·0
(−3·5 to
−4·5)
 Nicaragua 8·9 (8·0
to 9·7)
2·7 (2·5
to 2·9)
8·7 (7·5
to 10·3)
4·1 (3·2 to 5·1) 24·1
(22·0
to
26·7)
3·3 (3·0 to
3·7)
−5·1 (−4·3
to −5·9)
−3·8
(−3·0 to
−4·7)
−4·4
(−3·9 to
−4·9)
 Panama 5·9 (5·0
to 6·9)
2·2 (2·1
to 2·4)
4·4 (3·7
to 5·3)
6·2 (5·0 to 7·5) 18·7
(17·0
to
20·6)
1·4 (1·3 to
1·5)
−1·7 (−0·5
to −2·8)
−1·7
(−0·8 to
−2·6)
−1·7
(−1·1 to
−2·2)
 Venezuela 4·7 (4·2
to 5·2)
1·8 (1·7
to 1·9)
4·0 (3·6
to 4·4)
2·9 (2·3 to 3·5) 13·3
(12·5
to
14·1)
8·0 (7·5 to
8·5)
−3·6 (−3·4
to −3·7)
−3·5
(−3·0 to
−4·0)
−3·5
(−3·2 to
−3·8)
Southern Latin America 4·8 (3·3
to 6·9)
1·7 (1·3
to 2·1)
4·0 (3·1
to 5·3)
1·8 (1·2 to 2·6) 12·3
(9·2 to
16·5)
12·2 (9·1 to
16·4)
−4·1 (−3·9
to −4·3)
−2·5
(−0·2 to
−4·7)
−3·2
(−1·9 to
−4·4)
 Argentina 5·7 (4·0
to 8·0)
2·0 (1·6
to 2·4)
4·4 (3·6
to 5·7)
2·1 (1·4 to 3·1) 14·2
(10·8
to
18·5)
9·8 (7·5 to
12·8)
−3·9 (−3·6
to −4·1)
−2·5
(−0·3 to
−4·5)
−3·1
(−1·9 to
−4·2)
 Chile 2·6 (1·7
to 3·8)
1·0 (0·8
to 1·4)
2·8 (1·8
to 4·0)
1·1 (0·6 to 1·7) 7·4 (5·1
to
10·8)
1·8 (1·3 to
2·6)
−5·8 (−5·4
to −6·2)
−2·9
(0·0 to
−5·8)
−4·2
(−2·5 to
−5·7)
 Uruguay 3·6 (2·2
to 6·2)
1·8 (1·3
to 2·6)
4·3 (2·7
to 6·2)
1·3 (0·8 to 2·0) 10·9
(7·0 to
16·7)
0·5 (0·3 to
0·8)
−3·8 (−3·1
to −4·4)
−3·1
(0·3 to
−6·4)
−3·4
(−1·4 to
−5·2)
Tropical Latin America 7·5 (6·7
to 8·5)
2·6 (2·4
to 2·8)
6·1 (5·4
to 6·9)
2·0 (1·5 to 2·7) 18·1
(16·7
to
19·8)
57·4 (52·9
to 62·7)
−5·0 (−4·2
to −6·0)
−4·2
(−3·4 to
−5·0)
−4·6
(−4·1 to
−5·0)
 Brazil 7·5 (6·6
to 8·4)
2·6 (2·4
to 2·7)
6·1 (5·4
to 6·9)
1·9 (1·3 to 2·7) 18·0
(16·6
54·1 (49·8
to 59·0)
−5·1 (−4·3
to −6·0)
−4·3
(−3·5 to
−5·1)
−4·6
(−4·2 to
−5·1)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
to
19·7)
 Paraguay 8·9 (7·9
to 9·9)
2·7 (2·6
to 2·9)
5·6 (4·8
to 6·6)
3·9 (2·9 to 5·2) 21·0
(19·3
to
22·9)
3·4 (3·1 to
3·7)
−2·6 (−1·7
to −3·5)
−2·5
(−1·7 to
−3·3)
−2·6
(−2·1 to
−3·0)
North Africa and Middle
East
9·1 (8·5
to 9·8)
3·2 (3·0
to 3·4)
7·7 (7·0
to 8·6)
5·3 (4·7 to 6·0) 25·2
(23·4
to
27·1)
291·4
(271·2 to
313·9)
−4·6 (−4·2
to −5·0)
−4·6
(−4·0 to
−5·1)
−4·6
(−4·2 to
−4·9)
 Algeria 10·0 (8·8
to 11·4)
2·9 (2·7
to 3·3)
7·0 (5·7
to 8·7)
4·5 (3·3 to 5·9) 24·3
(21·2
to
28·0)
22·9 (20·1
to 26·4)
−4·2 (−3·3
to −5·2)
−3·5
(−2·4 to
−4·5)
−3·8
(−3·2 to
−4·5)
 Bahrain 2·5 (2·2
to 2·7)
1·3 (1·2
to 1·4)
2·2 (1·9
to 2·6)
0·9 (0·7 to 1·2) 6·9 (6·2
to 7·5)
0·1 (0·1 to
0·2)
−5·6 (−4·9
to −6·4)
−4·2
(−3·4 to
−5·1)
−4·8
(−4·4 to
−5·3)
 Egypt 7·3 (6·4
to 8·2)
3·5 (3·3
to 3·8)
6·5 (5·4
to 7·8)
4·7 (3·6 to 6·0) 21·8
(19·6
to
24·3)
41·3 (37·2
to 46·1)
−6·5 (−5·9
to −7·0)
−5·4
(−4·5 to
−6·2)
−5·8
(−5·3 to
−6·3)
 Iran 7·8 (6·5
to 9·2)
2·6 (2·3
to 2·8)
5·2 (4·3
to 6·4)
3·4 (2·5 to 4·6) 18·9
(16·4
to
21·9)
27·4 (23·7
to 31·8)
−6·0 (−5·1
to −6·9)
−6·3
(−5·2 to
−7·3)
−6·2
(−5·5 to
−6·8)
 Iraq 11·3
(10·3 to
12·4)
3·3 (3·0
to 3·7)
8·8 (7·0
to 10·7)
5·7 (3·9 to 7·8) 28·8
(26·2
to
31·7)
29·9 (27·3
to 33·0)
−2·1 (−1·4
to −2·8)
−3·1
(−2·2 to
−3·9)
−2·7
(−2·2 to
−3·1)
 Jordan 6·7 (5·8
to 7·6)
2·3 (2·1
to 2·4)
4·6 (3·8
to 5·4)
5·0 (3·9 to 6·1) 18·3
(16·7
to
20·2)
3·5 (3·2 to
3·9)
−2·3 (−1·6
to −2·9)
−2·9
(−2·1 to
−3·6)
−2·6
(−2·2 to
−3·1)
 Kuwait 3·1 (2·8
to 3·5)
1·3 (1·3
to 1·4)
2·7 (2·4
to 3·1)
1·8 (1·4 to 2·2) 8·9 (8·2
to 9·6)
0·6 (0·6 to
0·6)
−3·5 (−3·0
to −4·1)
−2·7
(−2·1 to
−3·4)
−3·1
(−2·7 to
−3·5)
 Lebanon 4·9 (4·1
to 5·9)
2·0 (1·7
to 2·3)
3·8 (3·1
to 4·5)
2·7 (1·9 to 3·8) 13·3
(11·7
to
15·2)
0·8 (0·7 to
0·9)
−6·1 (−5·0
to −7·1)
−3·9
(−2·7 to
−4·8)
−4·8
(−4·2 to
−5·4)
 Libya 5·1 (4·1
to 6·2)
2·0 (1·7
to 2·2)
4·2 (3·3
to 5·2)
3·2 (2·4 to 4·1) 14·3
(12·5
to
16·6)
1·9 (1·6 to
2·1)
−4·5 (−3·3
to −5·5)
−4·5
(−3·4 to
−5·5)
−4·5
(−3·8 to
−5·2)
 Morocco 10·5 (9·3
to 11·8)
4·1 (3·7
to 4·6)
7·4 (5·9
to 9·0)
4·5 (3·4 to 6·0) 26·3
(23·2
to
29·8)
19·4 (17·2
to 22·1)
−3·9 (−3·2
to −4·5)
−4·6
(−3·7 to
−5·5)
−4·3
(−3·7 to
−4·9)
 Oman 2·7 (2·3
to 3·3)
1·3 (1·2
to 1·5)
2·6 (2·1
to 3·1)
2·0 (1·5 to 2·6) 8·5 (7·4
to
10·0)
0·6 (0·5 to
0·7)
−7·1 (−5·9
to −8·2)
−6·6
(−5·4 to
−7·7)
−6·8
(−6·1 to
−7·5)
 Palestine 8·0 (6·6
to 9·5)
2·5 (2·3
to 2·8)
5·3 (4·4
to 6·5)
3·9 (2·7 to 5·3) 19·6
(17·0
to
22·8)
2·6 (2·2 to
3·0)
−4·0 (−2·9
to −5·1)
−3·5
(−2·3 to
−4·6)
−3·7
(−2·9 to
−4·4)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Qatar 3·5 (2·9
to 4·3)
1·6 (1·4
to 1·8)
3·1 (2·6
to 3·7)
2·2 (1·6 to 2·9) 10·3
(9·0 to
12·0)
0·2 (0·2 to
0·3)
−3·5 (−2·3
to −4·8)
−3·1
(−2·1 to
−4·1)
−3·3
(−2·5 to
−4·0)
 Saudi Arabia 4·3 (3·4
to 5·3)
1·8 (1·6
to 2·1)
3·5 (2·9
to 4·2)
2·5 (1·7 to 3·4) 12·0
(10·4
to
14·0)
6·8 (5·9 to
7·9)
−6·5 (−5·4
to −7·7)
−5·0
(−3·9 to
−6·1)
−5·7
(−5·0 to
−6·4)
 Sudan 15·5
(14·0 to
17·4)
4·7 (4·1
to 5·4)
14·2
(11·6 to
17·2)
13·4 (9·9 to 17·1) 47·1
(41·6
to
53·4)
59·5 (52·7
to 67·5)
−3·1 (−2·2
to −4·1)
−4·1
(−3·1 to
−5·0)
−3·6
(−3·1 to
−4·2)
 Syria 6·0 (5·2
to 6·8)
2·1 (2·0
to 2·2)
4·2 (3·4
to 5·1)
4·8 (3·7 to 5·9) 17·0
(15·8
to
18·3)
9·0 (8·4 to
9·7)
−6·5 (−5·6
to −7·5)
−2·1
(−1·2 to
−2·8)
−4·0
(−3·6 to
−4·4)
 Tunisia 5·1 (4·3
to 5·9)
2·2 (1·9
to 2·4)
4·0 (3·4
to 4·6)
3·0 (2·2 to 3·8) 14·1
(12·6
to
15·9)
2·7 (2·4 to
3·0)
−5·7 (−4·8
to −6·5)
−5·2
(−4·3 to
−6·1)
−5·4
(−4·9 to
−6·0)
 Turkey 7·3 (6·3
to 8·5)
2·5 (2·3
to 2·6)
5·4 (4·7
to 6·3)
2·3 (1·7 to 3·0) 17·4
(15·5
to
19·6)
22·0 (19·6
to 24·8)
−5·6 (−4·9
to −6·3)
−6·4
(−5·5 to
−7·2)
−6·0
(−5·5 to
−6·6)
 United Arab Emirates 2·2 (1·9
to 2·5)
1·1 (1·0
to 1·3)
2·0 (1·6
to 2·5)
1·4 (1·0 to 2·0) 6·8 (6·0
to 7·6)
0·9 (0·8 to
1·0)
−5·5 (−4·2
to −6·9)
−4·6
(−3·4 to
−5·7)
−5·0
(−4·3 to
−5·8)
 Yemen 15·3
(13·0 to
17·6)
5·7 (4·8
to 6·8)
20·7
(16·0 to
25·3)
9·6 (7·2 to 12·7) 50·4
(44·5
to
57·5)
38·0 (33·6
to 43·4)
−3·4 (−2·8
to −4·0)
−4·2
(−3·2 to
−5·1)
−3·9
(−3·3 to
−4·4)
High-income North America 2·9 (2·4
to 3·5)
0·7 (0·6
to 0·8)
1·9 (1·5
to 2·4)
1·1 (0·7 to 1·5) 6·5 (5·4
to 7·9)
30·1 (24·8
to 36·7)
−3·2 (−3·1
to −3·4)
−1·6
(−0·1 to
−3·1)
−2·3
(−1·5 to
−3·1)
 Canada 2·5 (2·0
to 3·0)
0·6 (0·5
to 0·7)
1·5 (1·2
to 1·9)
0·9 (0·6 to 1·3) 5·4 (4·4
to 6·6)
2·1 (1·7 to
2·6)
−3·5 (−3·0
to −4·0)
−0·9
(0·7 to
−2·4)
−2·1
(−1·2 to
−2·9)
 USA 2·9 (2·4
to 3·5)
0·7 (0·6
to 0·8)
1·9 (1·5
to 2·4)
1·1 (0·7 to 1·5) 6·6 (5·5
to 8·1)
28·0 (23·1
to 34·2)
−3·2 (−3·1
to −3·4)
−1·7
(−0·1 to
−3·1)
−2·3
(−1·5 to
−3·2)
Oceania 15·7
(12·3 to
19·9)
4·7 (3·0
to 7·3)
17·3
(10·1 to
26·9)
13·8 (6·9 to 25·8) 50·5
(32·6
to
76·5)
14·2 (9·2 to
21·4)
−1·1 (1·0
to −3·1)
−2·5
(0·1 to
−5·1)
−1·9
(0·0 to
−3·7)
 Federated States of
Micronesia
5·8 (3·0
to 10·1)
1·7 (1·1
to 2·2)
3·9 (2·4
to 6·3)
3·4 (1·9 to 5·6) 14·7
(8·9 to
23·5)
0·0 (0·0 to
0·1)
−5·9 (−2·9
to −8·8)
−4·7
(−1·7 to
−7·5)
−5·2
(−3·1 to
−7·2)
 Fiji 12·1 (8·7
to 15·8)
2·9 (2·0
to 4·3)
9·5 (5·1
to 16·6)
8·6 (5·0 to 14·3) 32·7
(21·5
to
48·9)
0·6 (0·4 to
0·9)
−0·7 (1·9
to −3·3)
0·3 (3·4
to −2·4)
−0·1
(2·4 to
−2·3)
 Kiribati 16·5
(13·2 to
20·6)
4·9 (3·2
to 7·2)
18·1
(10·7 to
28·4)
13·7 (7·2 to 23·6) 52·2
(35·6
to
75·4)
0·1 (0·1 to
0·2)
−2·5 (−0·3
to −4·7)
−2·3
(0·6 to
−5·0)
−2·4
(−0·6 to
−4·1)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Marshall Islands 12·3 (8·2
to 16·5)
2·9 (2·0
to 5·1)
9·5 (4·9
to 18·2)
7·4 (3·8 to 14·4) 31·8
(19·2
to
51·8)
0·1 (0·0 to
0·1)
−1·5 (1·5
to −4·5)
−2·1
(1·1 to
−5·3)
−1·9
(0·6 to
−4·0)
 Papua New Guinea 17·1
(13·6 to
21·7)
5·3 (3·3
to 8·3)
19·9
(11·5 to
30·6)
15·8 (7·5 to 30·5) 57·0
(36·7
to
86·4)
12·0 (7·7 to
18·1)
−1·4 (0·9
to −3·6)
−2·8
(−0·1 to
−5·4)
−2·2
(−0·3 to
−4·1)
 Samoa 4·5 (2·3
to 8·7)
1·4 (0·9
to 2·1)
3·2 (1·8
to 5·2)
3·1 (1·7 to 5·5) 12·1
(6·9 to
20·4)
0·1 (0·0 to
0·1)
−3·1 (0·3
to −6·7)
−2·7
(1·1 to
−6·1)
−2·9
(0·2 to
−5·7)
 Solomon Islands 9·0 (5·0
to 13·5)
2·2 (1·5
to 3·2)
5·8 (3·3
to 10·9)
5·0 (2·8 to 8·4) 21·8
(13·2
to
35·1)
0·4 (0·2 to
0·6)
−2·7 (0·2
to −5·6)
−3·1
(0·4 to
−6·0)
−2·9
(−0·8 to
−5·1)
 Tonga 9·6 (5·2
to 14·4)
2·3 (1·6
to 3·6)
6·4 (3·3
to 12·9)
5·4 (2·8 to 10·0) 23·5
(13·5
to
39·3)
0·1 (0·0 to
0·1)
0·6 (4·0 to
−2·7)
−1·9
(1·6 to
−5·3)
−0·8
(1·5 to
−3·1)
 Vanuatu 13·0 (9·7
to 16·3)
3·2 (2·2
to 4·7)
10·6 (6·0
to 17·4)
8·1 (4·6 to 13·9) 34·5
(23·5
to
50·0)
0·2 (0·2 to
0·3)
0·3 (2·5 to
−1·9)
−0·7
(2·3 to
−3·7)
−0·3
(1·6 to
−2·2)
Central sub–Saharan Africa 22·7
(20·0 to
25·8)
7·7 (6·5
to 9·1)
39·8
(32·6 to
48·6)
45·1 (33·7 to 60·0) 110·7
(93·0
to
130·9)
461·4
(386·8 to
547·7)
−0·7 (−0·2
to −1·2)
−3·0
(−1·6 to
−4·3)
−2·0
(−1·2 to
−2·8)
 Angola 16·6
(14·0 to
19·7)
8·6 (6·9
to 10·5)
29·5
(21·3 to
39·6)
38·3 (26·4 to 54·4) 90·1
(72·2
to
109·9)
83·4 (67·2
to 101·5)
−2·0 (−1·0
to −2·8)
−4·1
(−2·4 to
−5·8)
−3·2
(−2·3 to
−4·2)
 Central African Republic 29·6
(24·8 to
35·8)
11·6 (8·9
to 15·1)
50·3
(38·5 to
65·9)
53·4 (34·3 to 76·5) 137·7
(107·4
to
176·5)
21·5 (16·8
to 27·6)
−0·8 (0·1
to −1·7)
−1·4
(0·7 to
−3·2)
−1·1
(0·0 to
−2·2)
 Congo 17·7
(15·5 to
19·9)
4·8 (4·0
to 5·6)
21·8
(16·7 to
26·9)
18·1 (12·3 to 24·5) 61·1
(51·8
to
69·9)
10·0 (8·5 to
11·5)
1·9 (2·6–1·0) −4·6
(−3·4 to
−6·0)
−1·8
(−1·2 to
−2·6)
 Democratic Republic of
the Congo
24·7
(20·8 to
29·1)
7·5 (5·9
to 9·5)
44·2
(33·6 to
57·0)
49·3 (33·8 to 71·2) 120·3
(96·1
to
150·2)
340·4
(272·3 to
425·8)
−0·4 (0·2
to −1·1)
−2·8
(−1·0 to
−4·5)
−1·7
(−0·7 to
−2·7)
 Equatorial Guinea 23·9
(19·7 to
28·2)
8·4 (6·3
to 11·3)
40·4
(28·4 to
54·5)
41·1 (26·0 to 63·8) 109·4
(82·5
to
142·6)
2·9 (2·2 to
3·8)
0·1 (1·6 to
−1·1)
−3·4
(−0·8 to
−5·6)
−1·9
(−0·6 to
−3·2)
 Gabon 19·1
(16·5 to
21·4)
3·9 (3·2
to 4·6)
20·7
(16·1 to
25·1)
17·9 (13·0 to 23·7) 60·4
(50·5
to
71·2)
3·2 (2·7 to
3·8)
−1·9 (−1·0
to −2·8)
−1·3
(−0·1 to
−2·8)
−1·5
(−0·8 to
−2·3)
Eastern sub-Saharan Africa 19·6
(18·5 to
20·8)
6·3 (5·8
to 6·8)
26·8
(24·4 to
29·3)
25·9 (22·8 to 29·5) 76·5
(71·0
to
82·6)
1005·0
(932·7 to
1085·4)
−2·4 (−2·2
to −2·6)
−4·4
(−3·8 to
−5·0)
−3·5
(−3·2 to
−3·9)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Burundi 19·4
(16·6 to
22·4)
7·2 (6·1
to 8·5)
28·5
(22·8 to
34·7)
36·4 (27·0 to 49·1) 88·7
(75·3
to
104·8)
39·1 (33·2
to 46·3)
0·2 (0·9 to
−0·5)
−5·4
(−4·1 to
−6·8)
−3·0
(−2·2 to
−3·8)
 Comoros 18·2
(14·8 to
22·3)
6·3 (4·5
to 9·2)
13·6 (8·7
to 20·4)
8·5 (5·4 to 13·3) 45·8
(33·2
to
63·1)
1·2 (0·9 to
1·6)
−3·8 (−1·9
to −5·7)
−4·7
(−2·0 to
−7·0)
−4·3
(−2·9 to
−5·6)
 Djibouti 17·6
(15·1 to
21·0)
5·4 (4·0
to 7·1)
21·8
(15·1 to
29·7)
19·5 (12·3 to 30·9) 62·9
(47·3
to
82·1)
1·5 (1·1 to
2·0)
−0·9 (0·6
to −2·1)
−3·8
(−1·3 to
−6·0)
−2·5
(−1·3 to
−3·7)
 Eritrea 15·9
(13·4 to
18·9)
4·1 (3·0
to 5·7)
16·9
(11·7 to
24·0)
22·6 (14·0 to 36·7) 58·2
(41·9
to
79·9)
13·3 (9·6 to
18·2)
−2·8 (−2·1
to −3·6)
−5·3
(−2·8 to
−7·7)
−4·2
(−2·7 to
−5·5)
 Ethiopia 22·9
(20·0 to
26·1)
7·0 (5·8
to 8·4)
23·3
(18·3 to
28·9)
23·2 (16·7 to 32·6) 74·4
(62·7
to
88·4)
229·3
(193·4 to
273·0)
−3·5 (−2·9
to −4·1)
−5·1
(−3·8 to
−6·5)
−4·4
(−3·6 to
−5·2)
 Kenya 17·5
(15·1 to
20·5)
4·4 (3·4
to 5·6)
21·1
(15·4 to
28·7)
16·6 (11·2 to 23·2) 58·3
(46·5
to
73·4)
89·5 (71·4
to 112·8)
0·1 (0·8 to
−0·6)
−3·9
(−1·9 to
−5·6)
−2·2
(−1·0 to
−3·1)
 Madagascar 14·6
(12·5 to
17·0)
5·3 (4·2
to 6·7)
21·6
(16·2 to
28·4)
18·3 (12·5 to 26·2) 58·5
(46·5
to
73·7)
45·7 (36·3
to 57·7)
−4·1 (−3·5
to −4·8)
−3·9
(−2·1 to
−5·8)
−4·0
(−3·0 to
−5·0)
 Malawi 19·7
(16·9 to
22·1)
6·5 (5·5
to 7·4)
30·6
(24·7 to
36·5)
36·1 (26·8 to 46·9) 89·9
(76·5
to
103·4)
57·2 (48·7
to 65·9)
−3·1 (−2·6
to −3·7)
−4·8
(−3·5 to
−5·9)
−4·0
(−3·4 to
−4·7)
 Mauritius 6·2 (5·2
to 7·4)
1·9 (1·7
to 2·1)
3·3 (2·9
to 3·8)
2·6 (2·0 to 3·3) 14·0
(12·2
to
16·0)
0·2 (0·2 to
0·2)
−2·3 (−1·6
to −3·1)
−1·7
(−0·6 to
−2·8)
−2·0
(−1·4 to
−2·6)
 Seychelles 4·5 (3·6
to 5·5)
1·6 (1·4
to 1·9)
3·0 (2·5
to 3·6)
2·7 (1·9 to 3·7) 11·7
(10·1
to
13·7)
0·0 (0·0 to
0·0)
−2·8 (−1·0
to −4·5)
−0·9
(0·9 to
−2·3)
−1·7
(−0·8 to
−2·5)
 Mozambique 21·0
(18·4 to
23·9)
6·8 (5·7
to 7·8)
33·5
(26·6 to
41·0)
30·1 (21·4 to 39·8) 88·4
(76·9
to
101·5)
87·9 (76·3
to 101·1)
−3·4 (−2·9
to −4·0)
−4·4
(−3·3 to
−5·5)
−4·0
(−3·4 to
−4·6)
 Rwanda 17·6
(15·4 to
20·3)
5·4 (4·3
to 6·8)
21·6
(16·3 to
29·2)
19·5 (12·5 to 28·4) 62·6
(50·7
to
78·2)
25·7 (20·8
to 32·1)
−0·3 (0·2
to −1·0)
−7·2
(−5·4 to
−8·8)
−4·2
(−3·2 to
−5·1)
 Somalia 23·8
(19·8 to
28·2)
10·0 (7·5
to 13·0)
39·2
(27·3 to
53·1)
45·5 (29·5 to 67·2) 113·7
(88·9
to
144·5)
51·3 (40·1
to 65·3)
−1·8 (−0·7
to −2·8)
−2·6
(−0·5 to
−4·4)
−2·2
(−1·2 to
−3·3)
 South Sudan 23·0
(19·8 to
26·9)
9·0 (6·9
to 11·8)
36·9
(27·6 to
48·8)
41·1 (26·2 to 59·9) 105·9
(83·8
to
135·1)
41·8 (33·2
to 53·5)
−3·0 (−0·8
to −5·0)
−2·7
(−0·3 to
−4·8)
−2·8
(−1·6 to
−4·0)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Tanzania 18·0
(15·7 to
20·4)
5·8 (4·8
to 6·9)
30·2
(23·2 to
37·2)
24·6 (18·0 to 33·1) 76·5
(63·8
to
90·4)
145·2
(121·1 to
171·8)
−2·1 (−1·6
to −2·7)
−3·6
(−2·2 to
−5·0)
−3·0
(−2·2 to
−3·7)
 Uganda 20·2
(17·6 to
22·7)
5·7 (4·9
to 6·6)
27·9
(22·4 to
33·1)
28·8 (21·7 to 37·0) 80·1
(69·4
to
93·1)
127·3
(110·3 to
147·9)
−1·7 (−1·2
to −2·3)
−4·2
(−2·9 to
−5·3)
−3·1
(−2·4 to
−3·7)
 Zambia 15·2
(13·2 to
17·7)
6·9 (5·5
to 8·6)
29·5
(22·8 to
37·9)
31·2 (20·7 to 43·6) 80·5
(63·4
to
101·2)
48·7 (38·3
to 61·3)
−1·4 (−0·8
to −1·9)
−4·9
(−3·3 to
−6·7)
−3·4
(−2·4 to
−4·4)
Southern sub–Saharan Africa 13·8
(12·4 to
15·2)
4·2 (3·5
to 4·9)
17·5
(13·7 to
21·4)
12·3 (9·5 to 15·4) 46·9
(39·8
to
54·6)
83·2 (70·7
to 96·7)
1·3 (2·7 to
−0·3)
−4·1
(−2·5 to
−5·6)
−1·7
(−1·0 to
−2·5)
 Botswana 12·5
(10·1 to
14·8)
2·6 (2·0
to 3·7)
9·6 (6·3
to 15·1)
6·6 (3·9 to 10·5) 30·9
(22·4
to
41·9)
1·5 (1·1 to
2·0)
2·0 (3·3–0·7) −6·0
(−3·1 to
−8·4)
−2·5
(−1·2 to
−4·0)
 Lesotho 31·3
(26·3 to
37·2)
7·4 (5·8
to 9·7)
35·0
(26·9 to
47·6)
18·8 (12·5 to 27·0) 89·6
(71·3
to
113·8)
5·1 (4·0 to
6·5)
1·1 (2·0–0·1) −1·1
(0·9 to
−2·9)
−0·1
(1·0 to
−1·2)
 Namibia 14·0 (11·2-17·8)2·5 (1·7
to 3·7)
9·4 (5·8
to 15·6)
9·2 (5·5 to 15·3) 34·7
(24·2
to
49·0)
2·1 (1·4 to
2·9)
−1·0 (0·0
to −1·7)
−4·8
(−2·0 to
−7·4)
−3·1
(−1·6 to
−4·6)
 South Africa 11·4 (9·5
to 13·3)
3·2 (2·5
to 4·2)
14·7 (9·2
to 20·3)
8·2 (5·3 to 12·2) 37·0
(27·8
to
47·8)
40·6 (30·6
to 52·6)
1·4 (3·6 to
−1·0)
−6·1
(−3·6 to
−8·5)
−2·8
(−1·6 to
−4·1)
 Swaziland 16·8
(14·4 to
19·9)
5·0 (3·9
to 6·4)
34·5
(26·1 to
45·0)
20·1 (13·0 to 28·4) 74·4
(58·1
to
96·0)
2·8 (2·1 to
3·5)
2·9 (3·8–2·1) −2·4
(−0·4 to
−4·3)
−0·1
(1·2 to
−1·2)
 Zimbabwe 17·7
(15·4 to
20·8)
6·5 (5·3
to 8·1)
23·3
(18·5 to
30·6)
23·1 (16·0 to 31·0) 69·0
(56·3
to
84·7)
30·3 (24·7
to 37·2)
1·0 (1·6–0·3) −0·6
(1·0 to
−2·3)
0·1 (0·9
to −0·7)
Western sub-Saharan Africa 25·7
(23·7 to
27·7)
8·7 (8·1
to 9·3)
32·4
(29·2 to
35·8)
52·3 (45·7 to 59·6) 114·3
(106·8
to
122·1)
1645·9
(1537·4 to
1758·6)
−1·3 (−1·1
to −1·6)
−3·1
(−2·6 to
−3·6)
−2·3
(−2·0 to
−2·6)
 Benin 18·1
(16·0 to
20·3)
3·6 (3·2
to 4·1)
18·9
(15·8 to
22·2)
20·8 (16·1 to 26·7) 60·1
(54·1
to
67·1)
22·3 (20·0
to 24·9)
−3·1 (−2·6
to −3·6)
−5·9
(−4·9 to
−6·8)
−4·7
(−4·1 to
−5·1)
 Burkina Faso 20·2
(17·5 to
23·1)
8·7 (7·8
to 9·9)
32·3
(26·9 to
38·6)
46·6 (36·7 to 57·0) 104·0
(93·0
to
116·6)
70·6 (63·1
to 79·4)
−1·3 (−0·8
to −1·9)
−4·3
(−3·4 to
−5·2)
−3·0
(−2·5 to
−3·5)
 Cameroon 25·1
(22·5 to
28·4)
7·5 (6·8
to 8·5)
30·3
(25·9 to
35·5)
41·8 (33·5 to 52·5) 100·9
(91·9
to
113·9)
82·5 (75·1
to 93·2)
0·3 (0·9 to
−0·2)
−2·5
(−1·5 to
−3·4)
−1·3
(−0·7 to
−1·7)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 Cape Verde 9·1 (7·5
to 10·7)
2·4 (2·2
to 2·8)
7·3 (5·7
to 9·7)
5·5 (4·1 to 7·2) 24·1
(20·0
to
29·2)
0·2 (0·2 to
0·3)
−2·4 (−1·0
to −3·8)
−4·8
(−3·0 to
−6·4)
−3·8
(−2·9 to
−4·6)
 Chad 29·6
(25·2 to
34·5)
12·1
(10·0 to
14·6)
46·3
(34·9 to
59·9)
66·5 (47·9 to 84·6) 146·5
(128·2
to
170·3)
84·5 (74·0
to 98·5)
−0·7 (−0·1
to −1·3)
−2·0
(−0·7 to
−3·1)
−1·4
(−0·8 to
−2·0)
 Côte d’Ivoire 27·0
(24·0 to
30·1)
9·4 (8·4
to 10·7)
31·9
(27·0 to
38·0)
31·3 (24·8 to 40·5) 96·0
(86·7
to
108·9)
70·2 (63·3
to 79·5)
−0·8 (−0·2
to −1·4)
−3·0
(−1·9 to
−3·8)
−2·0
(−1·4 to
−2·5)
 Ghana 21·9
(19·1 to
24·8)
5·9 (5·1
to 6·8)
18·3
(14·9 to
22·1)
27·2 (21·5 to 34·2) 71·4
(62·4
to
82·3)
56·6 (49·4
to 65·2)
−1·8 (−1·3
to −2·3)
−2·8
(−1·7 to
−3·8)
−2·3
(−1·7 to
−2·9)
 Guinea 26·1
(22·9 to
29·2)
8·6 (7·8
to 9·5)
33·6
(28·0 to
38·9)
44·6 (35·8 to 53·6) 108·6
(99·6
to
117·7)
46·3 (42·4
to 50·3)
−2·8 (−2·3
to −3·4)
−3·6
(−2·9 to
−4·3)
−3·3
(−2·9 to
−3·7)
 Guinea–Bissau 30·0
(25·2 to
35·5)
12·3
(10·0 to
14·9)
47·6
(36·4 to
60·6)
71·2 (52·3 to 92·2) 152·5
(130·6
to
177·4)
9·6 (8·2 to
11·2)
−1·3 (−0·3
to −2·5)
−1·9
(−0·3 to
−3·2)
−1·6
(−0·8 to
−2·4)
 Liberia 20·4
(18·2 to
22·8)
5·9 (5·0
to 7·0)
32·6
(26·9 to
39·6)
20·8 (15·0 to 27·8) 77·5
(66·2
to
91·4)
11·6 (9·9 to
13·7)
−3·4 (−2·8
to −4·0)
−5·6
(−4·3 to
−6·9)
−4·6
(−3·9 to
−5·3)
 Mali 31·4
(26·0 to
36·9)
11·5 (9·6
to 13·9)
38·8
(30·4 to
48·6)
75·0 (58·5 to 96·3) 148·8
(126·4
to
176·0)
104·2 (88·5
to 123·0)
−1·5 (−1·0
to −2·0)
−3·0
(−1·7 to
−4·3)
−2·4
(−1·7 to
−3·1)
 Mauritania 26·8
(23·5 to
30·7)
6·7 (5·5
to 8·1)
16·0
(12·6 to
20·4)
21·6 (15·7 to 28·5) 69·3
(58·4
to
82·5)
9·1 (7·7 to
10·8)
−0·7 (0·2
to −1·6)
−2·7
(−1·2 to
−4·0)
−1·8
(−1·0 to
−2·6)
 Niger 17·7
(15·1 to
20·5)
8·3 (7·4
to 9·2)
31·3
(25·6 to
37·6)
62·6 (51·6 to 75·5) 115·4
(104·9
to
127·4)
97·8 (88·7
to 108·1)
−2·9 (−2·4
to −3·4)
−5·1
(−4·3 to
−5·9)
−4·1
(−3·7 to
−4·6)
 Nigeria 27·9
(23·9 to
31·7)
9·2 (8·1
to 10·4)
34·8
(28·6 to
41·1)
62·0 (49·8 to 76·1) 128·0
(114·3
to
142·0)
892·6
(796·1 to
991·6)
−1·2 (−0·7
to −1·7)
−2·8
(−1·9 to
−3·8)
−2·1
(−1·6 to
−2·6)
 São Tomé and Príncipe 15·2
(13·3 to
17·0)
3·2 (2·7
to 4·0)
11·7 (8·7
to 15·3)
11·2 (8·1 to 15·2) 40·7
(34·5
to
48·2)
0·3 (0·2 to
0·3)
−2·4 (−1·5
to −3·3)
−4·8
(−3·4 to
−6·1)
−3·8
(−3·0 to
−4·5)
 Senegal 18·0
(15·9 to
20·1)
5·6 (5·0
to 6·3)
14·8
(12·3 to
17·7)
22·4 (17·6 to 27·7) 59·5
(53·4
to
66·8)
31·1 (27·9
to 35·0)
−1·5 (−1·0
to −2·0)
−5·7
(−4·9 to
−6·6)
−3·9
(−3·4 to
−4·4)
 Sierra Leone 27·7
(24·1 to
31·4)
9·8 (8·5
to 11·4)
48·9
(40·2 to
58·7)
46·4 (34·3 to 60·0) 126·8
(111·6
to
144·3)
28·1 (24·7
to 32·0)
−1·4 (−0·9
to −2·0)
−3·5
(−2·5 to
−4·5)
−2·6
(−2·0 to
−3·2)
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Deaths per 1000 livebirths Number of
under to 5
deaths
(thousands)
Annualised rate of change
Early
neonatal
(0–6
days)
Late
neonatal
(7–28
days)
Post to
neonatal
(29–364
days)
Childhood (1–4 years) Under
5 (0–4
years)
1990–2000 2000–13 1990–13
 The Gambia 20·6
(18·1 to
23·7)
6·1 (5·0
to 7·6)
23·4
(17·9 to
29·9)
26·5 (17·9 to 36·1) 74·6
(62·2
to
90·0)
5·7 (4·8 to
6·9)
−2·6 (−1·4
to −3·7)
−4·0
(−2·5 to
−5·5)
−3·4
(−2·5 to
−4·2)
 Togo 25·2
(22·0 to
28·6)
6·1 (5·1
to 7·4)
26·2
(21·0 to
32·1)
38·4 (27·8 to 50·2) 92·8
(77·5
to
111·8)
22·6 (18·9
to 27·2)
−1·6 (−0·8
to −2·4)
−2·3
(−0·6 to
−3·7)
−2·0
(−1·2 to
−2·7)
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Table 4
Regression models for the log of the under–5 mortality rate for different model
specifications for 188 countries 1970–2013
Coefficient SE 95% CI
Lagged distributed income (logarithmic scale)
Mixed effects regression
−0·16‡ 0·007 −0·18 to −0·15
Within–between regression* −0·15‡ 0·013 −0·17 to −0·12
Generalised linear model
−0·15‡ 0·007 −0·17 to −0·14
Within–between regression† −0·15‡ 0·008 −0·17 to −0·14
Maternal education
Mixed effects regression
−0·08‡ 0·004 −0·09 to −0·08
Within–between regression* −0·09‡ 0·009 −0·11 to −0·07
Generalised linear model
−0·08‡ 0·004 −0·09 to −0·07
Within–between regression† −0·08‡ 0·004 −0·09 to −0·07
Crude death rate from HIV
Mixed effects regression 92·42‡ 4·137 84·31 to 100·52
Within–between regression* 56·42‡ 4·323 47·95 to 64·90
Generalised linear model 91·26‡ 4·098 83·22 to 99·29
Within–between regression† 91·26‡ 4·156 83·13 to 99·38
Combined GBD super–region and year fixed effects, and country level random effects, when included, not shown here.
*Within–between estimator with AR(1) autocorrelation specification.
†Within–between estimator without AR(1) autocorrelation specification.
‡Significant at 0·001 level.
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Table 5
Shapley decomposition analysis of the change in the number of under-5 deaths
(thousands) related to changes in income per person, maternal education, HIV child death
rate, births, secular trends, and unexplained factors, 2013 versus 1990, worldwide and in
the 21 GBD regions
Fertility Maternal education HIV/AIDS Income Unexplained Secular trend Total
Global 1423·6
(1412·9
to
1436·2)
−2223·8 (−2402·7 to
−2040·4)
32·4 (29·6
to 35·2)
−902·1
(−983·3
to
−821·1)
57·8 (−555·9
to 662·7)
−4170·4
(−4789 to
−3495·9)
−5782·5
(−5834·6
to
−5746·9)
High–income Asia Pacific −2·3
(−2·3 to
−2·3)
−1·6 (−1·8 to −1·5) 0 (0 to 0) −0·9 (−1
to −0·8)
0·6 (0 to 1·3) −5·3 (−6 to
−4·6)
−9·5
(−9·6 to
−9·5)
Central Asia −6·2
(−6·3 to
−6)
−19·8 (−21·5 to
−18·3)
0 (0 to 0) −2·7 (−3
to −2·4)
30·2 (22·5 to
38·7)
−67·3 (−75·9
to −59·8)
−65·7
(−66·4 to
−65·2)
East Asia −242·1
(−242·9
to
−241·4)
−195·4 (−211·1 to
−180·3)
0·3 (0·3 to
0·3)
−211·9
(−230·7
to
−192·8)
−316·4
(−368·1 to
−262·1)
−292·2
(−347·7 to
−237·9)
−1257·7
(−1259·2
to
−1256·4)
South Asia −78·5
(−82·5 to
−75·6)
−826·2 (−900·1 to
−752)
−7·9 (−8·6
to −7·2)
−405·1
(−447·9
to
−366·3)
492·2 (−38·6
to 1046)
−1608.0
(−2153·1 to
−1081·3)
−2433·5
(−2485·7
to
−2398·3)
Southeast Asia −19·7
(−19·8 to
−19·6)
−142·3 (−153·9 to
−131·3)
0·6 (0·5 to
0·6)
−73·6
(−80·3
to −67)
−65.0
(−107·4 to
−23)
−229·8
(−275·1 to
−185·8)
−529·8
(−531·4
to
−528·7)
Australasia 0·4 (0·4
to 0·4)
−0·3 (−0·4 to −0·3) 0 (0 to 0) −0·2
(−0·2 to
−0·2)
0·1 (−0·1 to
0·3)
−1·4 (−1·6 to
−1·2)
−1·4
(−1·4 to
−1·4)
Caribbean −1·2
(−1·2 to
−1·2)
−12·5 (−13·5 to
−11·5)
−1·6 (−1·8
to −1·5)
−0·5
(−0·6 to
−0·5)
0·7 (−2·4 to
3·9)
−16·5 (−19·7
to −13·2)
−31·7
(−31·8 to
−31·6)
Central Europe −7·1
(−7·2 to
−7·1)
−3·5 (−3·8 to −3·2) 0 (0 to 0) −1·4
(−1·5 to
−1·2)
−2·5 (−4 to
−0·9)
−13·4 (−15 to
−12)
−27·9
(−28·1 to
−27·8)
Eastern Europe −9·8
(−9·9 to
−9·6)
−7·1 (−7·7 to −6·6) 0 (0 to 0) −0·6
(−0·6 to
−0·5)
2·9 (−0·5 to
6·4)
−29·8 (−33·5
to −26·6)
−44·5
(−44·8 to
−44·2)
Western Europe 0·3 (0·3
to 0·3)
−5·3 (−5·7 to −4·9) 0 (0 to 0) −1·7
(−1·9 to
−1·6)
−1.0 (−2·9 to
1·1)
−16·8 (−19 to
−14·8)
−24·6
(−24·6 to
−24·5)
Andean Latin America 0·5 (0·5
to 0·5)
−16·4 (−17·7 to
−15·1)
0 (0 to 0) −3·8
(−4·1 to
−3·4)
−14·6 (−18·8
to −10·3)
−23·2 (−27·6
to −18·6)
−57·5
(−57·6 to
−57·5)
Central Latin America 0·8 (0·8
to 0·8)
−35·4 (−38·3 to
−32·7)
−0·1 (−0·2
to −0·1)
−6·5
(−7·1 to
−5·9)
−25·1 (−35·4
to −14·7)
−56·2 (−66·9
to −45)
−122·7
(−122·9
to
−122·5)
Southern Latin America −1·2
(−1·2 to
−1·2)
−4·4 (−4·8 to −4·1) 0 (0 to 0) −1·9
(−2·1 to
−1·8)
3·5 (2·2 to 5) −11·2 (−12·7
to −9·8)
−15·2
(−15·3 to
−15·1)
Tropical Latin America −19·4
(−19·4 to
−19·4)
−31 (−33·5 to −28·6) −0·2 (−0·2
to −0·2)
−5·2
(−5·7 to
−4·7)
−34·3 (−42·2
to −26·1)
−44·2 (−52·5
to −35·5)
−134·2
(−134·4
to
−134·2)
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Fertility Maternal education HIV/AIDS Income Unexplained Secular trend Total
North Africa and Middle
East
57·2
(56·1 to
58·5)
−139·7 (−150·9 to
−128·3)
0·3 (0·3 to
0·3)
−37·1
(−40·6
to
−33·8)
−27 (−72·6 to
17·7)
−321·9
(−368·3 to
−276·2)
−468·1
(−469·4
to
−467·3)
High-income North America 1·8 (1·8
to 1·9)
−2 (−2·2 to −1·9) −0·1 (−0·1
to −0·1)
−2·3
(−2·5 to
−2·1)
7·2 (4·4 to
10·3)
−23·4 (−26·6
to −20·5)
−18·8
(−18·9 to
−18·8)
Oceania 5 (4·9 to
5·1)
−4·1 (−4·4 to −3·7) 0 (0 to 0) −0·7
(−0·8 to
−0·6)
4·2 (3 to 5·5) −6·6 (−7·9 to
−5·3)
−2·1
(−2·1 to
−2·1)
Central sub–Saharan Africa 245·1
(243·6 to
246·9)
−99·5 (−107·6 to
−91·5)
3·6 (3·3 to
3·9)
31·6
(28·7 to
34·4)
30·9 (−0·6 to
62·5)
−183·1
(−214·1 to
−151·5)
28·6
(27·5 to
29·9)
Eastern sub–Saharan Africa 561
(559·2 to
563·6)
−240·9 (−260·5 to
−221·7)
−5·9 (−6·4
to −5·4)
−78·7
(−85·8
to
−71·5)
−219·2
(−297·9 to
−138·5)
−490·3
(−571·3 to
−407)
−474·1
(−474·6
to
−473·2)
Southern sub–Saharan Africa 5·6 (5·5
to 5·7)
−30 (−32·5 to −27·6) 2·5 (2·3 to
2·8)
−1·2
(−1·3 to
−1·1)
28 (21·4 to
34·9)
−38·5 (−45·2
to −31·8)
−33·6
(−33·8 to
−33·4)
Western sub–Saharan Africa 933·4
(927·4 to
940·8)
−406·2 (−439·5 to
−373·5)
40·9 (37·5
to 44·6)
−97·5
(−106·1
to
−88·5)
162·3 (47·5 to
281·2)
−691·3
(−808·8 to
−572·2)
−58·4
(−60·8 to
−55·2)
Lancet. Author manuscript; available in PMC 2014 September 16.
